Middle East Respiratory syndrome coronavirus: Another zoonotic betacoronavirus causing SARS-like disease

Clinical Microbiology Reviews

Volumn 28, Issue 2, 2015, Pages 465-522

  Chan, Jasper F W ^a,b   Lau, Susanna K P ^a,b   To, Kelvin K W ^a,b   Cheng, Vincent C C ^b   Woo, Patrick C Y ^a,b   Yue, Kwok Yung ^a,b  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CHYMOTRYPSIN; CYCLOSPORIN; DIPEPTIDYL PEPTIDASE IV; DRUG THERAPY; ELASTASE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GENOMIC RNA; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; LOPINAVIR; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID; RNA POLYMERASE; THERMOLYSIN; TRYPSIN; VITRONECTIN;

ANIMAL; ANTIBODY DETECTION; ARTICLE; BETACORONAVIRUS; CAMEL; CLASSIFICATION; CORONAVIRUS INFECTIONS; DISEASE MODEL; DISEASE SEVERITY; DISEASE SURVEILLANCE; EC50; EPIDEMIOLOGY; HEALTH CARE; HISTOPATHOLOGY; HUMAN; IC50; IMMUNE RESPONSE; INFECTION CONTROL; INFECTIOUS PNEUMONIA; MATHEMATICAL MODEL; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PATHOGENESIS; PATHOLOGY; PHYLOGENY; PHYSIOLOGY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SAFETY; SEROEPIDEMIOLOGY; SEROLOGY; SEVERE ACUTE RESPIRATORY SYNDROME LIKE DISEASE; TAXONOMY; THERAPY; TRANSMISSION; VACCINATION; VIROLOGY; VIRUS NOMENCLATURE; VIRUS REPLICATION; ZOONOSES; ZOONOSIS;

ANIMALS; ANTIVIRAL AGENTS; CLASSIFICATION; CORONAVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; EPIDEMIOLOGY; HUMANS; INFECTION CONTROL; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PATHOLOGY; PHYSIOLOGY; THERAPEUTIC USE; THERAPY; TRANSMISSION; VIROLOGY; ZOONOSES;

ANIMALIA; CAMELIDAE; CORONAVIRUS; PIPISTRELLUS; TYLONYCTERIS; VIVERRIDAE;

EID: 84959851955     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00102-14     Document Type: Article

References (345)

1. Chan JF, To KK, Tse H, Jin DY, Yuen KY. 2013. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol 21:544-555. http://dx.doi.org/10.1016/j.tim.2013.05 .005.
2. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319-1325. http://dx.doi.org/10 .1016/S0140-6736(03)13077-2.
3. Cheng VC, Lau SK, Woo PC, Yuen KY. 2007. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 20:660-694. http://dx.doi.org/10.1128/CMR.00023-07.
4. To KK, Chan JF, Chen H, Li L, Yuen KY. 2013. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect Dis 13:809-821. http://dx.doi.org/10 .1016/S1473-3099(13)70167-1.
5. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, Cheung PT, To WK, Ho ET, Sung R, Cheng AF. 1998. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351:467-471. http://dx.doi.org/10.1016 /S0140-6736(98)01182-9.
6. MacNeil A, Rollin PE. 2012. Ebola and Marburg hemorrhagic fevers: neglected tropical diseases? PLoS Negl Trop Dis 6:e1546. http://dx.doi .org/10.1371/journal.pntd.0001546.
7. Marsh GA, Wang LF. 2012. Hendra and Nipah viruses: why are they so deadly? Curr Opin Virol 2:242-247. http://dx.doi.org/10.1016/j.coviro .2012.03.006.
8. To KK, Ng KH, Que TL, Chan JM, Tsang KY, Tsang AK, Chen H, Yuen KY. 2012. Avian influenza A H5N1 virus: a continuous threat to humans. Emerg Microbes Infect 1:e25. http://dx.doi.org/10.1038/emi .2012.24.
9. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.NEngl J Med 367:1814-1820. http://dx.doi.org/10.1056 /NEJMoa1211721.
10. Chan JF, Li KS, To KK, Cheng VC, Chen H, Yuen KY. 2012. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoVEMC) the beginning of another SARS-like pandemic? J Infect 65:477-489. http://dx.doi.org/10.1016/j.jinf.2012.10.002.
11. Chan JF, Lau SK, Woo PC. 2013. The emerging novel Middle East respiratory syndrome coronavirus: the "knowns" and "unknowns." J Formos Med Assoc 112:372-381. http://dx.doi.org/10.1016/j.jfma.2013 .05.010.
12. Woo PC, Lau SK, Yuen KY. 2006. Infectious diseases emerging from Chinese wet-markets: zoonotic origins of severe respiratory viral infections. Curr Opin Infect Dis 19:401-407. http://dx.doi.org/10.1097/01 .qco.0000244043.08264.fc.
13. Woo PC, Wang M, Lau SK, Xu H, Poon RW, Guo R, Wong BH, Gao K, Tsoi HW, Huang Y, Li KS, Lam CS, Chan KH, Zheng BJ, Yuen KY. 2007. Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features. J Virol 81:1574-1585. http://dx.doi.org/10.1128/JVI.02182-06.
14. Woo PC, Lau SK, Li KS, Poon RW, Wong BH, Tsoi HW, Yip BC, Huang Y, Chan KH, Yuen KY. 2006. Molecular diversity of coronaviruses in bats. Virology 351:180-187. http://dx.doi.org/10.1016/j.virol .2006.02.041.
15. Woo PC, Lau SK, Huang Y, Yuen KY. 2009. Coronavirus diversity, phylogeny and interspecies jumping. Exp Biol Med (Maywood) 234: 1117-1127. http://dx.doi.org/10.3181/0903-MR-94.
16. van Boheemen S, de Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, Osterhaus AD, Haagmans BL, Gorbalenya AE, Snijder EJ, Fouchier RA. 2012. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio 3(6):e00473-12. http://dx.doi.org/10.1128/mBio.00473-12.
17. de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, Fouchier RA, Galiano M, Gorbalenya AE, Memish ZA, Perlman S, Poon LL, Snijder EJ, Stephens GM, Woo PC, Zaki AM, Zambon M, Ziebuhr J. 2013. Middle East respiratory syndrome coronavirus (MERSCoV): announcement of the Coronavirus Study Group. J Virol 87:7790-7792. http://dx.doi.org/10.1128/JVI.01244-13.
18. Bermingham A, Chand MA, Brown CS, Aarons E, Tong C, Langrish C, Hoschler K, Brown K, Galiano M, Myers R, Pebody RG, Green HK, Boddington NL, Gopal R, Price N, Newsholme W, Drosten C, Fouchier RA, Zambon M. 2012. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill 17(40):pii=20290. http: //www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20290.
19. Pollack MP, Pringle C, Madoff LC, Memish ZA. 2013. Latest outbreak news from ProMED-mail: novel coronavirus-Middle East. Int J Infect Dis 17:e143-144. http://dx.doi.org/10.1016/j.ijid.2012.12.001.
20. Cotten M, Lam TT, Watson SJ, Palser AL, Petrova V, Grant P, Pybus OG, Rambaut A, Guan Y, Pillay D, Kellam P, Nastouli E. 2013. Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus. Emerg Infect Dis 19:736-742B.
21. Woo PC, Lau SK, Li KS, Tsang AK, Yuen KY. 2012. Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5. Emerg Microbes Infect 1:e35. http://dx.doi.org/10.1038/emi.2012.45.
22. Frey KG, Redden CL, Bishop-Lilly KA, Johnson R, Hensley LE, Raviprakash K, Luke T, Kochel T, Mokashi VP, Defang GN. 2014. Full-genome sequence of human betacoronavirus 2c jordan-n3/2012 after serial passage in mammalian cells. Genome Announc 2(3):e00324-14. http://dx.doi.org/10.1128/genomeA.00324-14.
23. Qian Z, Dominguez SR, Holmes KV. 2013. Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERSCoV) in virus entry and syncytia formation. PLoS One 8:e76469. http: //dx.doi.org/10.1371/journal.pone.0076469.
24. Yang Y, Zhang L, Geng H, Deng Y, Huang B, Guo Y, Zhao Z, Tan W. 2013. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell 4:951-961. http://dx.doi .org/10.1007/s13238-013-3096-8.
25. Siu KL, Yeung ML, Kok KH, Yuen KS, Kew C, Lui PY, Chan CP, Tse H, Woo PC, Yuen KY, Jin DY. 2014. Middle East respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response. J Virol 88:4866-4876. http://dx.doi.org/10.1128/JVI .03649-13.
26. Matthews KL, Coleman CM, van der Meer Y, Snijder EJ, Frieman MB. 2014. The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling. J Gen Virol 95:874-882. http://dx.doi.org/10.1099/vir.0.062059-0.
27. Niemeyer D, Zillinger T, Muth D, Zielecki F, Horvath G, Suliman T, Barchet W, Weber F, Drosten C, Muller MA. 2013. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J Virol 87:12489-12495. http://dx.doi.org/10.1128/JVI.01845-13.
28. Yang X, Chen X, Bian G, Tu J, Xing Y, Wang Y, Chen Z. 2014. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease. J Gen Virol 95:614-626. http://dx.doi.org/10.1099/vir.0.059014-0.
29. Chen Y, Rajashankar KR, Yang Y, Agnihothram SS, Liu C, Lin YL, Baric RS, Li F. 2013. Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus. J Virol 87:10777-10783. http://dx.doi.org/10.1128/JVI.01756-13.
30. Lu G, Hu Y, Wang Q, Qi J, Gao F, Li Y, Zhang Y, Zhang W, Yuan Y, Bao J, Zhang B, Shi Y, Yan J, Gao GF. 2013. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 500:227-231. http://dx.doi.org/10.1038/nature12328.
31. Du L, Zhao G, Kou Z, Ma C, Sun S, Poon VK, Lu L, Wang L, Debnath AK, Zheng BJ, Zhou Y, Jiang S. 2013. Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development. J Virol 87:9939-9942. http://dx.doi.org/10.1128/JVI.01048-13.
32. Jiang S, Lu L, Du L, Debnath AK. 2013. A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC. J Infect 66:464-466. http://dx.doi.org/10.1016/j .jinf.2012.12.003.
33. Jiang S, Lu L, Du L, Debnath AK. 2013. Putative conformations of the receptor-binding domain in S protein of hCoV-EMC in complex with its receptor dipeptidyl peptidase-4. J Infect 67:156-158. http://dx.doi.org /10.1016/j.jinf.2013.04.007.
34. Mou H, Raj VS, van Kuppeveld FJ, Rottier PJ, Haagmans BL, Bosch BJ. 2013. The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. J Virol 87:9379-9383. http://dx.doi.org/10.1128/JVI.01277-13.
35. Wang N, Shi X, Jiang L, Zhang S, Wang D, Tong P, Guo D, Fu L, Cui Y, Liu X, Arledge KC, Chen YH, Zhang L, Wang X. 2013. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res 23:986-993. http://dx.doi.org/10.1038/cr.2013.92.
36. Ma C, Wang L, Tao X, Zhang N, Yang Y, Tseng CT, Li F, Zhou Y, Jiang S, Du L. 2014. Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments. The importance of immunofocusing in subunit vaccine design. Vaccine 32:6170-6176. http://dx.doi.org/10.1016/j.vaccine.2014.08.086.
37. Du L, Zhao G, Yang Y, Qiu H, Wang L, Kou Z, Tao X, Yu H, Sun S, Tseng CT, Jiang S, Li F, Zhou Y. 2014. A conformation-dependent neutralizing monoclonal antibody specifically targeting receptorbinding domain in middle East respiratory syndrome coronavirus spike protein. J Virol 88:7045-7053. http://dx.doi.org/10.1128/JVI.00433-14.
38. Ying T, Du L, Ju TW, Prabakaran P, Lau CC, Lu L, Liu Q, Wang L, Feng Y, Wang Y, Zheng BJ, Yuen KY, Jiang S, Dimitrov DS. 2014. Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. J Virol 88:7796-7805. http://dx.doi.org/10.1128/JVI.00912-14.
39. Jiang L, Wang N, Zuo T, Shi X, Poon KM, Wu Y, Gao F, Li D, Wang R, Guo J, Fu L, Yuen KY, Zheng BJ, Wang X, Zhang L. 2014. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Sci Transl Med 6:234ra259. http: //dx.doi.org/10.1126/scitranslmed.3008140.
40. Tang XC, Agnihothram SS, Jiao Y, Stanhope J, Graham RL, Peterson EC, Avnir Y, Tallarico AS, Sheehan J, Zhu Q, Baric RS, Marasco WA. 2014. Identification of human neutralizing antibodies against MERSCoV and their role in virus adaptive evolution. Proc Natl Acad Sci U S A 111:E2018-E2026. http://dx.doi.org/10.1073/pnas.1402074111.
41. Zhao G, Du L, Ma C, Li Y, Li L, Poon VK, Wang L, Yu F, Zheng BJ, Jiang S, Zhou Y. 2013. A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV. Virol J 10:266. http://dx.doi.org/10.1186/1743-422X-10-266.
42. Du L, Kou Z, Ma C, Tao X, Wang L, Zhao G, Chen Y, Yu F, Tseng CT, Zhou Y, Jiang S. 2013. A truncated receptor-binding domain of MERSCoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines. PLoS One 8:e81587. http://dx.doi.org/10.1371 /journal.pone.0081587.
43. Ma C, Li Y, Wang L, Zhao G, Tao X, Tseng CT, Zhou Y, Du L, Jiang S. 2014. Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: implication for designing novel mucosal MERS vaccines. Vaccine 32:2100-2108. http: //dx.doi.org/10.1016/j.vaccine.2014.02.004.
44. Lu L, Liu Q, Zhu Y, Chan KH, Qin L, Li Y, Wang Q, Chan JF, Du L, Yu F, Ma C, Ye S, Yuen KY, Zhang R, Jiang S. 2014. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Commun 5:3067. http://dx.doi.org/10.1038/ncomms4067.
45. Gao J, Lu G, Qi J, Li Y, Wu Y, Deng Y, Geng H, Li H, Wang Q, Xiao H, Tan W, Yan J, Gao GF. 2013. Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus. J Virol 87:13134- 13140. http://dx.doi.org/10.1128/JVI.02433-13.
46. Raj VS, Mou H, Smits SL, Dekkers DH, Muller MA, Dijkman R, Muth D, Demmers JA, Zaki A, Fouchier RA, Thiel V, Drosten C, Rottier PJ, Osterhaus AD, Bosch BJ, Haagmans BL. 2013. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495:251-254. http://dx.doi.org/10.1038/nature12005.
47. Lambeir AM, Durinx C, Scharpe S, De Meester I. 2003. Dipeptidylpeptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 40:209-294. http://dx.doi.org/10.1080/713609354.
48. van Doremalen N, Miazgowicz KL, Milne-Price S, Bushmaker T, Robertson S, Scott D, Kinne J, McLellan JS, Zhu J, Munster VJ. 2014. Host species restriction of Middle East respiratory syndrome coronavirus through its receptor dipeptidyl peptidase 4. J Virol 88:9220-9232. http://dx.doi.org/10.1128/JVI.00676-14.
49. Raj VS, Smits SL, Provacia LB, van den Brand JM, Wiersma L, Ouwendijk WJ, Bestebroer TM, Spronken MI, van Amerongen G, Rottier PJ, Fouchier RA, Bosch BJ, Osterhaus AD, Haagmans BL. 2014. Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus. J Virol 88:1834-1838. http://dx.doi.org/10.1128/JVI.02935-13.
50. Ohnuma K, Haagmans BL, Hatano R, Raj VS, Mou H, Iwata S, Dang NH, Bosch BJ, Morimoto C. 2013. Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody. J Virol 87:13892-13899. http://dx.doi.org/10.1128/JVI.02448-13.
51. Gierer S, Bertram S, Kaup F, Wrensch F, Heurich A, Kramer-Kuhl A, Welsch K, Winkler M, Meyer B, Drosten C, Dittmer U, von Hahn T, Simmons G, Hofmann H, Pohlmann S. 2013. The spike protein of the emerging betacoronavirusEMCuses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol 87:5502-5511. http://dx.doi.org/10.1128/JVI.00128-13.
52. Shirato K, Kawase M, Matsuyama S. 2013. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J Virol 87:12552-12561. http://dx.doi.org/10.1128 /JVI.01890-13.
53. Gierer S, Muller MA, Heurich A, Ritz D, Springstein B, Karsten CB, Schendzielorz A, Gnirss K, Drosten C, Pohlmann S. 23 July 2014. Inhibition of proprotein convertases abrogates processing of the MERScoronavirus spike protein in infected cells but does not reduce viral infectivity. J Infect Dis http://dx.doi.org/10.1093/infdis/jiu407.
54. Millet JK, Whittaker GR. 2014. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc Natl Acad Sci U S A 111:15214-15219. http://dx .doi.org/10.1073/pnas.1407087111.
55. Thomas G. 2002. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 3:753-766. http://dx.doi .org/10.1038/nrm934.
56. Hallenberger S, Bosch V, Angliker H, Shaw E, Klenk HD, Garten W. 1992. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature 360:358-361. http://dx.doi.org/10.1038/360358a0.
57. Shiryaev SA, Remacle AG, Ratnikov BI, Nelson NA, Savinov AY, Wei G, Bottini M, Rega MF, Parent A, Desjardins R, Fugere M, Day R, Sabet M, Pellecchia M, Liddington RC, Smith JW, Mustelin T, Guiney DG, Lebl M, Strongin AY. 2007. Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens. J Biol Chem 282:20847-20853. http://dx.doi.org/10.1074/jbc .M703847200.
58. de Wilde AH, Raj VS, Oudshoorn D, Bestebroer TM, van Nieuwkoop S, Limpens RW, Posthuma CC, van der Meer Y, Barcena M, Haagmans BL, Snijder EJ, van den Hoogen BG. 2013. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment. J Gen Virol 94: 1749-1760. http://dx.doi.org/10.1099/vir.0.052910-0.
59. Lu L, Liu Q, Du L, Jiang S. 2013. Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread. Microbes Infect 15:625-629. http://dx.doi.org/10 .1016/j.micinf.2013.06.003.
60. Lei J, Mesters JR, Drosten C, Anemuller S, Ma Q, Hilgenfeld R. 2014. Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features. Antiviral Res 109C:72-82. http://dx.doi.org/10.1016/j.antiviral.2014.06.011.
61. Stadler K, Masignani V, Eickmann M, Becker S, Abrignani S, Klenk HD, Rappuoli R. 2003. SARS-beginning to understand a new virus. Nat Rev Microbiol 1:209-218. http://dx.doi.org/10.1038/nrmicro775.
62. Corman VM, Muller MA, Costabel U, Timm J, Binger T, Meyer B, Kreher P, Lattwein E, Eschbach-Bludau M, Nitsche A, Bleicker T, Landt O, Schweiger B, Drexler JF, Osterhaus AD, Haagmans BL, Dittmer U, Bonin F, Wolff T, Drosten C. 2012. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill 17(49):pii=20334. http://www.eurosurveillance.org/View Article.aspx?ArticleId=20334.
63. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeem RF, Makhdoom HQ, Zumla AI, Memish ZA. 2013. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 13:752-761. http://dx.doi.org/10.1016/S1473 -3099(13)70204-4.
64. Albarrak AM, Stephens GM, Hewson R, Memish ZA. 2012. Recovery from severe novel coronavirus infection. Saudi Med J 33:1265-1269.
65. Memish ZA, Zumla AI, Assiri A. 2013. Middle East respiratory syndrome coronavirus infections in health care workers. N Engl J Med 369: 884-886. http://dx.doi.org/10.1056/NEJMc1308698.
66. Al-Abdallat MM, Payne DC, Alqasrawi S, Rha B, Tohme RA, Abedi GR, Al Nsour M, Iblan I, Jarour N, Farag NH, Haddadin A, Al- Sanouri T, Tamin A, Harcourt JL, Kuhar DT, Swerdlow DL, Erdman DD, Pallansch MA, Haynes LM, Gerber SI. 2014. Hospital-associated outbreak of middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis 59:1225-1233. http://dx.doi.org/10.1093/cid/ciu359.
67. Memish ZA, Zumla AI, Al-Hakeem RF, Al-Rabeeah AA, Stephens GM. 2013. Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med 368:2487-2494. http://dx.doi.org/10.1056 /NEJMoa1303729.
68. Mailles A, Blanckaert K, Chaud P, van der Werf S, Lina B, Caro V, Campese C, Guery B, Prouvost H, Lemaire X, Paty MC, Haeghebaert S, Antoine D, Ettahar N, Noel H, Behillil S, Hendricx S, Manuguerra JC, Enouf V, La Ruche G, Semaille C, Coignard B, Levy-Bruhl D, Weber F, Saura C, Che D. 2013. First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigationsandimplications for the prevention ofhumanto- human transmission, France, May 2013. Euro Surveill 18(24):pii=20502. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20502.
69. Guberina H, Witzke O, Timm J, Dittmer U, Muller MA, Drosten C, Bonin F. 2014. A patient with severe respiratory failure caused by novel human coronavirus. Infection 42:203-206. http://dx.doi.org/10.1007 /s15010-013-0509-9.
70. Omrani AS, Matin MA, Haddad Q, Al-Nakhli D, Memish ZA, Albarrak AM. 2013. A family cluster of Middle East respiratory syndrome coronavirus infections related to a likely unrecognized asymptomatic or mild case. Int J Infect Dis 17:e668-672. http://dx.doi.org/10.1016/j.ijid .2013.07.001.
71. Guery B, Poissy J, el Mansouf L, Sejourne C, Ettahar N, Lemaire X, Vuotto F, Goffard A, Behillil S, Enouf V, Caro V, Mailles A, Che D, Manuguerra JC, Mathieu D, Fontanet A, van der Werf S. 2013. Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission. Lancet 381:2265-2272. http://dx.doi.org/10.1016/S0140-6736(13)60982-4.
72. Drosten C, Seilmaier M, Corman VM, Hartmann W, Scheible G, Sack S, Guggemos W, Kallies R, Muth D, Junglen S, Muller MA, Haas W, Guberina H, Rohnisch T, Schmid-Wendtner M, Aldabbagh S, Dittmer U, Gold H, Graf P, Bonin F, Rambaut A, Wendtner CM. 2013. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 13:745-751. http://dx .doi.org/10.1016/S1473-3099(13)70154-3.
73. Health Protection Agency (HPA) UK Novel Coronavirus Investigation Team. 2013. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Euro Surveill 18(11):pii=20427. http://www.eurosurveillance .org/ViewArticle.aspx?ArticleId=20427.
74. Abroug F, Slim A, Ouanes-Besbes L, Hadj Kacem MA, Dachraoui F, Ouanes I, Lu X, Tao Y, Paden C, Caidi H, Miao C, Al-Hajri MM, Zorraga M, Ghaouar W, BenSalah A, Gerber SI, World Health Organization Global Outbreak Alert and Response Network Middle East Respiratory Syndrome Coroanvirus International Investigation Team. 2014. Family cluster of Middle East respiratory syndrome coronavirus infections, Tunisia, 2013. Emerg Infect Dis 20:1527-1530. http://dx.doi .org/10.3201/eid2009.140378.
75. Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, Alabdullatif ZN, Assad M, Almulhim A, Makhdoom H, Madani H, Alhakeem R, Al-Tawfiq JA, Cotten M, Watson SJ, Kellam P, Zumla AI, Memish ZA. 2013. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 369:407-416. http://dx.doi.org/10 .1056/NEJMoa1306742.
76. Tsiodras S, Baka A, Mentis A, Iliopoulos D, Dedoukou X, Papamavrou G, Karadima S, Emmanouil M, Kossyvakis A, Spanakis N, Pavli A, Maltezou H, Karageorgou A, Spala G, Pitiriga V, Kosmas E, Tsiagklis S, Gkatzias S, Koulouris N, Koutsoukou A, Bakakos P, Markozanhs E, Dionellis G, Pontikis K, Rovina N, Kyriakopoulou M, Efstathiou P, Papadimitriou T, Kremastinou J, Tsakris A, Saroglou G. 2014. A case of imported Middle East respiratory syndrome coronavirus infection and public health response, Greece, April 2014. Euro Surveill 19(16): pii=20782. http://www.eurosurveillance.org.
77. Bialek SR, Allen D, Alvarado-Ramy F, Arthur R, Balajee A, Bell D, Best S, Blackmore C, Breakwell L, Cannons A, Brown C, Cetron M, Chea N, Chommanard C, Cohen N, Conover C, Crespo A, Creviston J, Curns AT, Dahl R, Dearth S, DeMaria A, Echols F, Erdman DD, Feikin D, Frias M, Gerber SI, Gulati R, Hale C, Haynes LM, Heberlein- Larson L, Holton K, Ijaz K, Kapoor M, Kohl K, Kuhar DT, Kumar AM, Kundich M, Lippold S, Liu L, Lovchik JC, Madoff L, Martell S, Matthews S, Moore J, Murray LR, Onofrey S, Pallansch MA, Pesik N, Pham H, Pillai S, Pontones P, Pringle K, Pritchard S, Rasmussen S, Richards S, Sandoval M, Schneider E, Schuchat A, Sheedy K, Sherin K, Swerdlow DL, Tappero JW, Vernon MO, Watkins S, Watson J. 2014. First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities-May 2014.MMWRMorb Mortal Wkly Rep 63:431-436.
78. Premila Devi J, Noraini W, Norhayati R, Chee Kheong C, Badrul AS, Zainah S, Fadzilah K, Hirman I, Lokman Hakim S, Noor Hisham A. 2014. Laboratory-confirmed case of Middle East respiratorysyndromecoronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014. Euro Surveill 19(18):pii=20797. http://www.eurosurveillance .org/ViewArticle.aspx?ArticleId=20797.
79. Kraaij-Dirkzwager M, Timen A, Dirksen K, Gelinck L, Leyten E, Groeneveld P, Jansen C, Jonges M, Raj S, Thurkow I, van Gageldonk- Lafeber R, van der Eijk A, Koopmans M. 2014. Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014. Euro Surveill 19(21):pii=20817. http: //www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20817.
80. Al-Tawfiq JA, Hinedi K, Ghandour J, Khairalla H, Musleh S, Ujayli A, Memish ZA. 2014. Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients. Clin Infect Dis 59:160-165. http://dx.doi.org/10.1093/cid/ciu226.
81. Kapoor M, Pringle K, Kumar A, Dearth S, Liu L, Lovchik J, Perez O, Pontones P, Richards S, Yeadon-Fagbohun J, Breakwell L, Chea N, Cohen NJ, Schneider E, Erdman D, Haynes L, Pallansch M, Tao Y, Tong S, Gerber S, Swerdlow D, Feikin DR. 2014. Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States. Clin Infect Dis 59:1511-1518. http://dx.doi.org/10.1093/cid/ciu635.
82. Drosten C, Muth D, Corman V, Hussain R, Al Masri M, HajOmar W, Landt O, Assiri A, Eckerle I, Al Shangiti A, Al-Tawfiq JA, Albarrak A, Zumla A, Rambaut A, Memish Z. 16 October 2014. An observational, laboratory-based study of outbreaks of MERS-coronavirus in Jeddah and Riyadh, Kingdom of Saudi Arabia, 2014. Clin Infect Dis http://dx.doi.org /10.1093/cid/ciu812.
83. Memish ZA, Cotten M, Watson SJ, Kellam P, Zumla A, Alhakeem RF, Assiri A, Rabeeah AA, Al-Tawfiq JA. 2014. Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study. Int J Infect Dis 23:63-68. http://dx.doi.org/10.1016/j.ijid.2014.03.1372.
84. Pebody RG, Chand MA, Thomas HL, Green HK, Boddington NL, Carvalho C, Brown CS, Anderson SR, Rooney C, Crawley-Boevey E, Irwin DJ, Aarons E, Tong C, Newsholme W, Price N, Langrish C, Tucker D, Zhao H, Phin N, Crofts J, Bermingham A, Gilgunn-Jones E, Brown KE, Evans B, Catchpole M, Watson JM. 2012. The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. Euro Surveill 17(40):pii=20292. http://www .eurosurveillance.org/ViewArticle.aspx?ArticleId=20292.
85. Drosten C, Meyer B, Muller MA, Corman VM, Al-Masri M, Hossain R, Madani H, Sieberg A, Bosch BJ, Lattwein E, Alhakeem RF, Assiri AM, Hajomar W, Albarrak AM, Al-Tawfiq JA, Zumla AI, Memish ZA. 2014. Transmission of MERS-coronavirus in household contacts.NEngl J Med 371:828-835. http://dx.doi.org/10.1056/NEJMoa1405858.
86. Penttinen PM, Kaasik-Aaslav K, Friaux A, Donachie A, Sudre B, Amato-Gauci AJ, Memish ZA, Coulombier D. 2013. Taking stock of the first 133 MERS coronavirus cases globally-is the epidemic changing? Euro Surveill 18(39):pii=20596. http://www.eurosurveillance.org/View Article.aspx?ArticleId=20596.
87. WHO MERS-CoV Research Group. 2013. State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans. PLoS Curr 5:ecurrents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8. http: //dx.doi.org/10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8.
88. Arabi YM, Arifi AA, Balkhy HH, Najm H, Aldawood AS, Ghabashi A, Hawa H, Alothman A, Khaldi A, Al Raiy B. 2014. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 160:389-397. http://dx.doi.org /10.7326/M13-2486.
89. Alghamdi IG, Hussain II, Almalki SS, Alghamdi MS, Alghamdi MM, El-Sheemy MA. 2014. The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health. Int J Gen Med 7:417-423. http: //dx.doi.org/10.2147/IJGM.S67061.
90. Breban R, Riou J, Fontanet A. 2013. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 382:694-699. http://dx.doi.org/10.1016/S0140-6736(13)61492-0.
91. Alqurashi KA, Aljabri KS, Bokhari SA. 2011. Prevalence of diabetes mellitus in a Saudi community. Ann Saudi Med 31:19-23. http://dx.doi .org/10.4103/0256-4947.75773.
92. Zumla AI, Memish ZA. 2014. Middle East respiratory syndrome coronavirus: epidemic potential or a storm in a teacup? Eur Respir J 43:1243-1248. http://dx.doi.org/10.1183/09031936.00227213.
93. Woo PC, Lau SK, Chu CM, Chan KH, Tsoi HW, Huang Y, Wong BH, Poon RW, Cai JJ, Luk WK, Poon LL, Wong SS, Guan Y, Peiris JS, Yuen KY. 2005. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 79:884-895. http://dx.doi.org/10.1128/JVI.79.2.884-895.2005.
94. Woo PC, Lau SK, Tsoi HW, Huang Y, Poon RW, Chu CM, Lee RA, Luk WK, Wong GK, Wong BH, Cheng VC, Tang BS, Wu AK, Yung RW, Chen H, Guan Y, Chan KH, Yuen KY. 2005. Clinical and molecular epidemiological features of coronavirus HKU1-associated community- acquired pneumonia. J Infect Dis 192:1898-1907. http://dx.doi.org /10.1086/497151.
95. Lau SK, Woo PC, Yip CC, Tse H, Tsoi HW, Cheng VC, Lee P, Tang BS, Cheung CH, Lee RA, So LY, Lau YL, Chan KH, Yuen KY. 2006. Coronavirus HKU1 and other coronavirus infections in Hong Kong. J Clin Microbiol 44:2063-2071. http://dx.doi.org/10.1128/JCM.02614-05.
96. Chan CM, Tse H, Wong SS, Woo PC, Lau SK, Chen L, Zheng BJ, Huang JD, Yuen KY. 2009. Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus. J Clin Virol 45:54-60. http: //dx.doi.org/10.1016/j.jcv.2009.02.011.
97. Gierer S, Hofmann-Winkler H, Albuali WH, Bertram S, Al-Rubaish AM, Yousef AA, Al-Nafaie AN, Al-Ali AK, Obeid OE, Alkharsah KR, Pohlmann S. 2013. Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia. Emerg Infect Dis 19:2034-2036. http://dx.doi.org/10.3201/eid1912.130701.
98. Aburizaiza AS, Mattes FM, Azhar EI, Hassan AM, Memish ZA, Muth D, Meyer B, Lattwein E, Muller MA, Drosten C. 2014. Investigation of anti-Middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012. J Infect Dis 209:243-246. http://dx.doi.org/10.1093/infdis/jit589.
99. Lau SK, Li KS, Tsang AK, Lam CS, Ahmed S, Chen H, Chan KH, Woo PC, Yuen KY. 2013. Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. J Virol 87:8638-8650. http://dx.doi.org/10.1128/JVI.01055-13.
100. Yang Y, Du L, Liu C, Wang L, Ma C, Tang J, Baric RS, Jiang S, Li F. 2014. Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission ofMERScoronavirus. Proc Natl Acad SciUSA 111:12516-12521. http://dx.doi.org/10.1073/pnas.1405889111.
101. Wang Q, Qi J, Yuan Y, Xuan Y, Han P, Wan Y, Ji W, Li Y, Wu Y, Wang J, Iwamoto A, Woo PC, Yuen KY, Yan J, Lu G, Gao GF. 2014. Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. Cell Host Microbe 16:328-337. http://dx.doi.org /10.1016/j.chom.2014.08.009.
102. Lau SK, Woo PC, Li KS, Huang Y, Tsoi HW, Wong BH, Wong SS, Leung SY, Chan KH, Yuen KY. 2005. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci U S A 102:14040-14045. http://dx.doi.org/10.1073/pnas.0506735102.
103. Woo PC, Lau SK, Lam CS, Lau CC, Tsang AK, Lau JH, Bai R, Teng JL, Tsang CC, Wang M, Zheng BJ, Chan KH, Yuen KY. 2012. Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J Virol 86:3995-4008. http: //dx.doi.org/10.1128/JVI.06540-11.
104. Lau SK, Woo PC, Li KS, Huang Y, Wang M, Lam CS, Xu H, Guo R, Chan KH, Zheng BJ, Yuen KY. 2007. Complete genome sequence of bat coronavirusHKU2from Chinese horseshoe bats revealed a much smaller spike gene with a different evolutionary lineage from the rest of the genome. Virology 367:428-439. http://dx.doi.org/10.1016/j.virol.2007.06 .009.
105. Lau SK, Li KS, Huang Y, Shek CT, Tse H, Wang M, Choi GK, Xu H, Lam CS, Guo R, Chan KH, Zheng BJ, Woo PC, Yuen KY. 2010. Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events. J Virol 84:2808-2819. http://dx.doi .org/10.1128/JVI.02219-09.
106. Lau SK, Poon RW, Wong BH, Wang M, Huang Y, Xu H, Guo R, Li KS, Gao K, Chan KH, Zheng BJ, Woo PC, Yuen KY. 2010. Coexistence of different genotypes in the same bat and serological characterization of Rousettus bat coronavirus HKU9 belonging to a novel Betacoronavirus subgroup. J Virol 84:11385-11394. http://dx.doi.org/10.1128/JVI.01121-10.
107. Lau SK, Li KS, Tsang AK, Shek CT, Wang M, Choi GK, Guo R, Wong BH, Poon RW, Lam CS, Wang SY, Fan RY, Chan KH, Zheng BJ, Woo PC, Yuen KY. 2012. Recent transmission of a novel alphacoronavirus, bat coronavirus HKU10, from Leschenault's rousettes to pomona leafnosed bats: first evidence of interspecies transmission of coronavirus between bats of different suborders. J Virol 86:11906-11918. http://dx .doi.org/10.1128/JVI.01305-12.
108. Cui J, Eden JS, Holmes EC, Wang LF. 2013. Adaptive evolution of bat dipeptidyl peptidase 4 (dpp4): implications for the origin and emergence of Middle East respiratory syndrome coronavirus. Virol J 10:304. http: //dx.doi.org/10.1186/1743-422X-10-304.
109. Memish ZA, Mishra N, Olival KJ, Fagbo SF, Kapoor V, Epstein JH, Alhakeem R, Durosinloun A, Al Asmari M, Islam A, Kapoor A, Briese T, Daszak P, Al Rabeeah AA, Lipkin WI. 2013. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis 19:1819- 1823.
110. Ithete NL, Stoffberg S, Corman VM, Cottontail VM, Richards LR, Schoeman MC, Drosten C, Drexler JF, Preiser W. 2013. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis 19:1697-1699. http://dx.doi.org/10.3201/eid1910.130946.
111. Corman VM, Ithete NL, Richards LR, Schoeman MC, Preiser W, Drosten C, Drexler JF. 2014. Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat. J Virol 88:11297-11303. http://dx.doi.org /10.1128/JVI.01498-14.
112. Cotten M, Watson SJ, Kellam P, Al-Rabeeah AA, Makhdoom HQ, Assiri A, Al-Tawfiq JA, Alhakeem RF, Madani H, AlRabiah FA, Al Hajjar S, Al-nassir WN, Albarrak A, Flemban H, Balkhy HH, Alsubaie S, Palser AL, Gall A, Bashford-Rogers R, Rambaut A, Zumla AI, Memish ZA. 2013. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet 382:1993-2002. http://dx.doi.org/10.1016/S0140-6736(13)61887-5.
113. Corman VM, Kallies R, Philipps H, Gopner G, Muller MA, Eckerle I, Brunink S, Drosten C, Drexler JF. 2014. Characterization of a novel betacoronavirus related to middle East respiratory syndrome coronavirus in European hedgehogs. J Virol 88:717-724. http://dx.doi.org/10 .1128/JVI.01600-13.
114. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, Luo SW, Li PH, Zhang LJ, Guan YJ, Butt KM, Wong KL, Chan KW, Lim W, Shortridge KF, Yuen KY, Peiris JS, Poon LL. 2003. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302:276 -278. http://dx.doi.org/10 .1126/science.1087139.
115. Wong S, Lau S, Woo P, Yuen KY. 2007. Bats as a continuing source of emerging infections in humans. Rev Med Virol 17:67-91. http://dx.doi .org/10.1002/rmv.520.
116. Chan JF, Chan KH, Choi GK, To KK, Tse H, Cai JP, Yeung ML, Cheng VC, Chen H, Che XY, Lau SK, Woo PC, Yuen KY. 2013. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J Infect Dis 207:1743-1752. http://dx.doi.org/10.1093/infdis/jit123.
117. Muller MA, Raj VS, Muth D, Meyer B, Kallies S, Smits SL, Wollny R, Bestebroer TM, Specht S, Suliman T, Zimmermann K, Binger T, Eckerle I, Tschapka M, Zaki AM, Osterhaus AD, Fouchier RA, Haagmans BL, Drosten C. 2012. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. mBio 3(6):e00515-12. http://dx.doi.org/10 .1128/mBio.00515-12.
118. Eckerle I, Corman VM, Muller MA, Lenk M, Ulrich RG, Drosten C. 2014. Replicative capacity ofMERScoronavirus in livestock cell lines.EmergInfect Dis 20:276-279. http://dx.doi.org/10.3201/eid2002.131182.
119. Cockrell AS, Peck KM, Yount BL, Agnihothram SS, Scobey T, Curnes NR, Baric RS, Heise MT. 2014. Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection. J Virol 88:5195-5199. http://dx.doi.org/10.1128/JVI.03764-13.
120. Barlan A, Zhao J, Sarkar MK, Li K, McCray PB, Jr, Perlman S, Gallagher T. 2014. Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection. J Virol 88:4953-4961. http: //dx.doi.org/10.1128/JVI.00161-14.
121. Reusken CB, Haagmans BL, Muller MA, Gutierrez C, Godeke GJ, Meyer B, Muth D, Raj VS, Smits-De Vries L, Corman VM, Drexler JF, Smits SL, El Tahir YE, De Sousa R, van Beek J, Nowotny N, van Maanen K, Hidalgo-Hermoso E, Bosch BJ, Rottier P, Osterhaus A, Gortazar-Schmidt C, Drosten C, Koopmans MP. 2013. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis 13:859-866. http://dx.doi.org/10.1016/S1473-3099(13)70164-6.
122. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, Siu LY, Shehata MM, Kayed AS, Moatasim Y, Li M, Poon LL, Guan Y, Webby RJ, Ali MA, Peiris JS, Kayali G. 2013. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill 18(36):pii=20574. http://www .eurosurveillance.org/ViewArticle.aspx?ArticleId=20574.
123. Alagaili AN, Briese T, Mishra N, Kapoor V, Sameroff SC, Burbelo PD, de Wit E, Munster VJ, Hensley LE, Zalmout IS, Kapoor A, Epstein JH, Karesh WB, Daszak P, Mohammed OB, Lipkin WI. 2014. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. mBio 5(2): e00884-00814. http://dx.doi.org/10.1128/mBio.00884-14.
124. Meyer B, Muller MA, Corman VM, Reusken CB, Ritz D, Godeke GJ, Lattwein E, Kallies S, Siemens A, van Beek J, Drexler JF, Muth D, Bosch BJ, Wernery U, Koopmans MP, Wernery R, Drosten C. 2014. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis 20:552-559. http://dx .doi.org/10.3201/eid2004.131746.
125. Alexandersen S, Kobinger GP, Soule G, Wernery U. 2014. Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005. Transbound Emerg Dis 61:105-108. http://dx.doi.org/10.1111/tbed.12212.
126. Reusken CB, Ababneh M, Raj VS, Meyer B, Eljarah A, Abutarbush S, Godeke GJ, Bestebroer TM, Zutt I, Muller MA, Bosch BJ, Rottier PJ, Osterhaus AD, Drosten C, Haagmans BL, Koopmans MP. 2013. Middle East respiratory syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013. Euro Surveill 18(50):pii=20662. http://www.eurosurveillance.org /ViewArticle.aspx?ArticleId=20662.
127. Hemida MG, Perera RA, Wang P, Alhammadi MA, Siu LY, Li M, Poon LL, Saif L, Alnaeem A, Peiris M. 2013. Middle East respiratory syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. Euro Surveill 18(50):pii=20659. http://www .eurosurveillance.org/ViewArticle.aspx?ArticleId=20659.
128. Memish ZA, Cotten M, Meyer B, Watson SJ, Alsahafi AJ, Al Rabeeah AA, Corman VM, Sieberg A, Makhdoom HQ, Assiri A, Al Masri M, Aldabbagh S, Bosch BJ, Beer M, Muller MA, Kellam P, Drosten C. 2014. Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis 20:1012-1015. http: //dx.doi.org/10.3201/eid2006.140402.
129. Hemida MG, Chu DK, Poon LL, Perera RA, Alhammadi MA, Ng HY, Siu LY, Guan Y, Alnaeem A, Peiris M. 2014. MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerg Infect Dis 20:1231-1234. http://dx.doi.org/10.3201/eid2007.140571.
130. Corman VM, Jores J, Meyer B, Younan M, Liljander A, Said MY, Gluecks I, Lattwein E, Bosch BJ, Drexler JF, Bornstein S, Drosten C, Muller MA. 2014. Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013. Emerg Infect Dis 20:1319-1322. http://dx.doi .org/10.3201/eid2008.140596.
131. Raj VS, Farag EA, Reusken CB, Lamers MM, Pas SD, Voermans J, Smits SL, Osterhaus AD, Al-Mawlawi N, Al-Romaihi HE, AlHajri MM, El- Sayed AM, Mohran KA, Ghobashy H, Alhajri F, Al-Thani M, Al-Marri SA, El-Maghraby MM, Koopmans MP, Haagmans BL. 2014. Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014. Emerg Infect Dis 20:1339-1342. http://dx.doi.org/10.3201/eid2008.140663.
132. Müller MA, Corman VM, Jores J, Meyer B, Younan M, Liljander A, Bosch BJ, Lattwein E, Hilali M, Musa BE, Bornstein S, Drosten C. December 2014. MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997. Emerg Infect Dis http://dx.doi.org/10.3201 /eid2012.141026..
133. Haagmans BL, Al Dhahiry SH, Reusken CB, Raj VS, Galiano M, Myers R, Godeke GJ, Jonges M, Farag E, Diab A, Ghobashy H, Alhajri F, Al-Thani M, Al-Marri SA, Al Romaihi HE, Al Khal A, Bermingham A, Osterhaus AD, AlHajri MM, Koopmans MP. 2014. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis 14:140-145. http://dx.doi.org/10.1016/S1473 -3099(13)70690-X.
134. Chu DK, Poon LL, Gomaa MM, Shehata MM, Perera RA, Abu Zeid D, El Rifay AS, Siu LY, Guan Y, Webby RJ, Ali MA, Peiris M, Kayali G. 2014. MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis 20:1049-1053. http://dx.doi.org/10.3201/eid2006.140299.
135. Hemida M, Perera R, Al Jassim R, Kayali G, Siu L, Wang P, Chu K, Perlman S, Ali M, Alnaeem A, Guan Y, Poon L, Saif L, Peiris M. 2014. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill 19(23):pii=20828. http://www.eurosurveillance .org/ViewArticle.aspx?ArticleId=20828.
136. Memish ZA, Alsahly A, Masri MA, Heil GL, Anderson BD, Peiris M, Khan SU, Gray GC. 3 December 2014. Sparse evidence of MERS-CoV infection among animal workers living in Southern Saudi Arabia during 2012. Influenza Other Respir Viruses http://dx.doi.org/10.1111/irv.12287.
137. Briese T, Mishra N, Jain K, Zalmout IS, Jabado OJ, Karesh WB, Daszak P, Mohammed OB, Alagaili AN, Lipkin WI. 2014. Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia. mBio 5(3):e01146- 01114. http://dx.doi.org/10.1128/mBio.01146-14.
138. Azhar EI, El-Kafrawy SA, Farraj SA, Hassan AM, Al-Saeed MS, Hashem AM, Madani TA. 2014. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 370:2499-2505. http://dx .doi.org/10.1056/NEJMoa1401505.
139. Azhar EI, Hashem AM, El-Kafrawy SA, Sohrab SS, Aburizaiza AS, Farraj SA, Hassan AM, Al-Saeed MS, Jamjoom GA, Madani TA. 2014. Detection of the Middle East respiratory syndrome coronavirus genome in an air sample originating from a camel barn owned by an infected patient. mBio 5(4): e01450-01414. http://dx.doi.org/10.1128/mBio.01450-14.
140. Woo PC, Lau SK, Wernery U, Wong EY, Tsang AK, Johnson B, Yip CC, Lau CC, Sivakumar S, Cai JP, Fan RY, Chan KH, Mareena R, Yuen KY. 2014. Novel betacoronavirus in dromedaries of the Middle East, 2013. Emerg Infect Dis 20:560-572. http://dx.doi.org/10.3201 /eid2004.131769.
141. Muyldermans S. 2001. Single domain camel antibodies: current status. J Biotechnol 74:277-302. http://dx.doi.org/10.1016/S1389-0352(01)00021-6.
142. Fanoy EB, van der Sande MA, Kraaij-Dirkzwager M, Dirksen K, Jonges M, van der Hoek W, Koopmans MP, van der Werf D, Sonder G, van der Weijden C, van der Heuvel J, Gelinck L, Bouwhuis JW, van Gageldonk-Lafeber AB. 2014. Travel-related MERS-CoV cases: an assessment of exposures and risk factors in a group of Dutch travellers returning from the Kingdom of Saudi Arabia, May 2014. Emerg Themes Epidemiol 11:16. http://dx.doi.org/10.1186/1742-7622-11-16.
143. van Doremalen N, Bushmaker T, Karesh WB, Munster VJ. 2014. Stability of Middle East respiratory syndrome coronavirus in milk. Emerg Infect Dis 20:1263-1264. http://dx.doi.org/10.3201/eid2007.140500.
144. Reusken CB, Farag EA, Jonges M, Godeke GJ, El-Sayed AM, Pas SD, Raj VS, Mohran KA, Moussa HA, Ghobashy H, Alhajri F, Ibrahim AK, Bosch BJ, Pasha SK, Al-Romaihi HE, Al-Thani M, Al-Marri SA, AlHajri MM, Haagmans BL, Koopmans MP. 2014. Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014. Euro Surveill 19(23):pii=20829. http://www .eurosurveillance.org/ViewArticle.aspx?ArticleId=20829.
145. van Doremalen N, Bushmaker T, Munster VJ. 2013. Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Euro Surveill 18(38):pii=20590. http://www .eurosurveillance.org/ViewArticle.aspx?ArticleId=20590.
146. Cotten M, Watson SJ, Zumla AI, Makhdoom HQ, Palser AL, Ong SH, Al Rabeeah AA, Alhakeem RF, Assiri A, Al-Tawfiq JA, Albarrak A, Barry M, Shibl A, Alrabiah FA, Hajjar S, Balkhy HH, Flemban H, Rambaut A, Kellam P, Memish ZA. 2014. Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. mBio 5(1):e01062-13. http://dx.doi.org/10.1128/mBio.01062-13.
147. Li W, Zhang C, Sui J, Kuhn JH, Moore MJ, Luo S, Wong SK, Huang IC, Xu K, Vasilieva N, Murakami A, He Y, Marasco WA, Guan Y, Choe H, Farzan M. 2005. Receptor and viral determinants of SARScoronavirus adaptation to human ACE2. EMBO J 24:1634-1643. http: //dx.doi.org/10.1038/sj.emboj.7600640.
148. Sheahan T, Rockx B, Donaldson E, Sims A, Pickles R, Corti D, Baric R. 2008. Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium. J Virol 82:2274-2285. http://dx.doi.org/10.1128/JVI.02041-07.
149. McRoy WC, Baric RS. 2008. Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansion. J Virol 82:1414-1424. http://dx.doi.org/10.1128/JVI.01674-07.
150. Poletto C, Pelat C, Levy-Bruhl D, Yazdanpanah Y, Boelle PY, Colizza V. 2014. Assessment of the Middle East respiratory syndrome coronavirus(MERS-CoV) epidemic in the Middle East and risk of international spread using a novel maximum likelihood analysis approach. Euro Surveill 19(23):pii=20824. http: //www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20824.
151. Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, Rambaut A, Enouf V, van der Werf S, Ferguson NM. 2014. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis 14: 50-56. http://dx.doi.org/10.1016/S1473-3099(13)70304-9.
152. Ajlan AM, Ahyad RA, Jamjoom LG, Alharthy A, Madani TA. 2014. Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. AJR Am J Roentgenol 203:782-787. http://dx.doi.org /10.2214/AJR.14.13021.
153. Cheng VC, To KK, Tse H, Hung IF, Yuen KY. 2012. Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev 25:223-263. http://dx.doi.org/10.1128/CMR.05012-11.
154. To KK, Chan JF, Yuen KY. 2014. Viral lung infections: epidemiology, virology, clinical features, and management of avian influenza A(H7N9). Curr Opin Pulm Med 20:225-232. http://dx.doi.org/10 .1097/MCP.0000000000000047.
155. Yu L, Wang Z, Chen Y, Ding W, Jia H, Chan JF, To KK, Chen H, Yang Y, Liang W, Zheng S, Yao H, Yang S, Cao H, Dai X, Zhao H, Li J, Bao Q, Chen P, Hou X, Li L, Yuen KY. 2013. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus. Clin Infect Dis 57:1449-1457. http://dx.doi.org /10.1093/cid/cit541.
156. To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, Liu R, Ho KY, Chu KH, Watt CL, Luk WK, Lai KY, Chow FL, Mok T, Buckley T, Chan JF, Wong SS, Zheng B, Chen H, Lau CC, Tse H, Cheng VC, Chan KH, Yuen KY. 2010. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 50:850-859. http://dx.doi.org/10.1086 /650581.
157. Eckerle I, Muller MA, Kallies S, Gotthardt DN, Drosten C. 2013. In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East respiratory syndrome (MERS) coronavirus infection. Virol J 10:359. http://dx .doi.org/10.1186/1743-422X-10-359.
158. Chu KH, Tsang WK, Tang CS, Lam MF, Lai FM, To KF, Fung KS, Tang HL, Yan WW, Chan HW, Lai TS, Tong KL, Lai KN. 2005. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int 67:698-705. http://dx.doi.org/10.1111/j.1523-1755 .2005.67130.x.
159. Fowler RA, Lapinsky SE, Hallett D, Detsky AS, Sibbald WJ, Slutsky AS, Stewart TE. 2003. Critically ill patients with severe acute respiratory syndrome. JAMA 290:367-373. http://dx.doi.org/10.1001/jama.290.3.367.
160. Hung IF, Cheng VC, Wu AK, Tang BS, Chan KH, Chu CM, Wong MM, Hui WT, Poon LL, Tse DM, Chan KS, Woo PC, Lau SK, Peiris JS, Yuen KY. 2004. Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis 10:1550-1557. http://dx.doi.org/10.3201 /eid1009.040058.
161. Park SJ, Kim GY, Choy HE, Hong YJ, Saif LJ, Jeong JH, Park SI, Kim HH, Kim SK, Shin SS, Kang MI, Cho KO. 2007. Dual enteric and respiratory tropisms of winter dysentery bovine coronavirus in calves. Arch Virol 152: 1885-1900. http://dx.doi.org/10.1007/s00705-007-1005-2.
162. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH, Ng JS, Zheng BJ, Ng WL, Lai RW, Guan Y, Yuen KY. 2003. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361:1767-1772. http://dx.doi.org/10.1016/S0140-6736(03)13412-5.
163. Memish ZA, Al-Tawfiq JA, Assiri A, Alrabiah FA, Hajjar SA, Albarrak A, Flemban H, Alhakeem RF, Makhdoom HQ, Alsubaie S, Al-Rabeeah AA. 2014. Middle East respiratory syndrome coronavirus disease in children. Pediatr Infect Dis J 33:904-906. http://dx.doi.org/10.1097/INF .0000000000000325.
164. Munster VJ, de Wit E, Feldmann H. 2013. Pneumonia from human coronavirus in a macaque model. N Engl J Med 368:1560-1562. http: //dx.doi.org/10.1056/NEJMc1215691.
165. de Wit E, Rasmussen AL, Falzarano D, Bushmaker T, Feldmann F, Brining DL, Fischer ER, Martellaro C, Okumura A, Chang J, Scott D, Benecke AG, Katze MG, Feldmann H, Munster VJ. 2013. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A 110:16598-16603. http://dx.doi.org/10.1073/pnas.1310744110.
166. Yao Y, Bao L, Deng W, Xu L, Li F, Lv Q, Yu P, Chen T, Xu Y, Zhu H, Yuan J, Gu S, Wei Q, Chen H, Yuen KY, Qin C. 2014. An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus. J Infect Dis 209:236-242. http://dx.doi.org/10.1093/infdis/jit590.
167. Falzarano D, de Wit E, Feldmann F, Rasmussen AL, Okumura A, Peng X, Thomas MJ, van Doremalen N, Haddock E, Nagy L, LaCasse R, Liu T, Zhu J, McLellan JS, Scott DP, Katze MG, Feldmann H, Munster VJ. 2014. Infection with MERS-CoV causes lethal pneumonia in the common marmoset. PLoS Pathog 10:e1004250. http://dx.doi.org/10.1371 /journal.ppat.1004250.
168. Prescott J, de Wit E, Falzarano D, Scott DP, Feldmann H, Munster VJ. 2014. Defining the effects of immunosuppression in the rhesus model of Middle East respiratory syndrome (MERS). Final Progr 33rd Annu Meet Am Soc Virol, Fort Collins, CO.
169. Menachery VD, Eisfeld AJ, Schafer A, Josset L, Sims AC, Proll S, Fan S, Li C, Neumann G, Tilton SC, Chang J, Gralinski LE, Long C, Green R, Williams CM, Weiss J, Matzke MM, Webb-Robertson BJ, Schepmoes AA, Shukla AK, Metz TO, Smith RD, Waters KM, Katze MG, Kawaoka Y, Baric RS. 2014. Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferonstimulated gene responses. mBio 5(3):e01174-01114. http://dx.doi.org /10.1128/mBio.01174-14.
170. Lau SK, Lau CC, Chan KH, Li CP, Chen H, Jin DY, Chan JF, Woo PC, Yuen KY. 2013. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. J Gen Virol 94:2679-2690. http://dx.doi.org/10.1099/vir.0.055533-0.
171. Mielech AM, Kilianski A, Baez-Santos YM, Mesecar AD, Baker SC. 2014. MERS-CoV papain-like protease has deISGylating and deubiquitinating activities. Virology 450-451:64-70. http://dx.doi.org/10.1016/j .virol.2013.11.040.
172. Deng X, Agnihothram S, Mielech AM, Nichols DB, Wilson MW, StJohn SE, Larsen SD, Mesecar AD, Lenschow DJ, Baric RS, Baker SC. 2014. A chimeric virus-mouse model system for evaluating the function and inhibition of papain-like proteases of emerging coronaviruses. J Virol 88:11825-11833. http://dx.doi.org/10.1128/JVI.01749-14.
173. Zhao J, Li K, Wohlford-Lenane C, Agnihothram SS, Fett C, Gale MJ, Jr, Baric RS, Enjuanes L, Gallagher T, McCray PB, Jr, Perlman S. 2014. Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci U S A 111:4970-4975. http://dx.doi.org/10 .1073/pnas.1323279111.
174. Falzarano D, de Wit E, Rasmussen AL, Feldmann F, Okumura A, Scott DP, Brining D, Bushmaker T, Martellaro C, Baseler L, Benecke AG, Katze MG, Munster VJ, Feldmann H. 2013. Treatment with interferonalpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med 19:1313-1317. http://dx.doi.org/10.1038/nm.3362.
175. Faure E, Poissy J, Goffard A, Fournier C, Kipnis E, Titecat M, Bortolotti P, Martinez L, Dubucquoi S, Dessein R, Gosset P, Mathieu D, Guery B. 2014. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside? PLoS One 9:e88716. http://dx .doi.org/10.1371/journal.pone.0088716.
176. Josset L, Menachery VD, Gralinski LE, Agnihothram S, Sova P, Carter VS, Yount BL, Graham RL, Baric RS, Katze MG. 2013. Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. mBio 4(3):e00165- 00113. http://dx.doi.org/10.1128/mBio.00165-13.
177. Cameron MJ, Ran L, Xu L, Danesh A, Bermejo-Martin JF, Cameron CM, Muller MP, Gold WL, Richardson SE, Poutanen SM, Willey BM, DeVries ME, Fang Y, Seneviratne C, Bosinger SE, Persad D, Wilkinson P, Greller LD, Somogyi R, Humar A, Keshavjee S, Louie M, Loeb MB, Brunton J, McGeer AJ, Kelvin DJ. 2007. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol 81:8692-8706. http://dx.doi.org/10.1128/JVI.00527-07.
178. Perlman S, Netland J. 2009. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol 7:439-450. http://dx.doi .org/10.1038/nrmicro2147.
179. Ryzhakov G, Lai CC, Blazek K, To KW, Hussell T, Udalova I. 2011. IL-17 boosts proinflammatory outcome of antiviral response in human cells. J Immunol 187:5357-5362. http://dx.doi.org/10.4049/jimmunol .1100917.
180. Crowe CR, Chen K, Pociask DA, Alcorn JF, Krivich C, Enelow RI, Ross TM, Witztum JL, Kolls JK. 2009. Critical role of IL-17RA in immunopathology of influenza infection. J Immunol 183:5301-5310. http://dx.doi.org/10.4049/jimmunol.0900995.
181. Poissy J, Goffard A, Parmentier-Decrucq E, Favory R, Kauv M, Kipnis E, Mathieu D, Guery B. 2014. Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases. J Clin Virol 61:275-278. http://dx.doi.org/10.1016/j.jcv.2014.07.002.
182. Buchholz U, Muller MA, Nitsche A, Sanewski A, Wevering N, Bauer- Balci T, Bonin F, Drosten C, Schweiger B, Wolff T, Muth D, Meyer B, Buda S, Krause G, Schaade L, Haas W. 2013. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill 18(8):pii=20406. http: //www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20406.
183. Spanakis N, Tsiodras S, Haagmans BL, Raj VS, Pontikis K, Koutsoukou A, Koulouris NG, Osterhaus AD, Koopmans MP, Tsakris A. 2014. Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen. Int J Antimicrob Agents 44:528-532. http://dx.doi.org/10.1016 /j.ijantimicag.2014.07.026.
184. Tao X, Hill TE, Morimoto C, Peters CJ, Ksiazek TG, Tseng CT. 2013. Bilateral entry and release of Middle East respiratory syndrome coronavirus induces profound apoptosis of human bronchial epithelial cells. J Virol 87:9953-9958. http://dx.doi.org/10.1128/JVI.01562-13.
185. Zielecki F, Weber M, Eickmann M, Spiegelberg L, Zaki AM, Matrosovich M, Becker S, Weber F. 2013. Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J Virol 87:5300-5304. http://dx.doi.org/10.1128/JVI.03496-12.
186. Kindler E, Jonsdottir HR, Muth D, Hamming OJ, Hartmann R, Rodriguez R, Geffers R, Fouchier RA, Drosten C, Muller MA, Dijkman R, Thiel V. 2013. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. mBio 4(1): e00611-00612. http://dx.doi.org/10.1128/mBio.00611-12.
187. Scobey T, Yount BL, Sims AC, Donaldson EF, Agnihothram SS, Menachery VD, Graham RL, Swanstrom J, Bove PF, Kim JD, Grego S, Randell SH, Baric RS. 2013. Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus. Proc Natl Acad Sci U S A 110:16157-16162. http://dx.doi.org/10.1073/pnas .1311542110.
188. Hocke AC, Becher A, Knepper J, Peter A, Holland G, Tonnies M, Bauer TT, Schneider P, Neudecker J, Muth D, Wendtner CM, Ruckert JC, Drosten C, Gruber AD, Laue M, Suttorp N, Hippenstiel S, Wolff T. 2013. Emerging human middle East respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs. Am J Respir Crit Care Med 188:882-886. http://dx.doi.org/10.1164 /rccm.201305-0954LE.
189. Chan RW, Chan MC, Agnihothram S, Chan LL, Kuok DI, Fong JH, Guan Y, Poon LL, Baric RS, Nicholls JM, Peiris JS. 2013. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J Virol 87: 6604-6614. http://dx.doi.org/10.1128/JVI.00009-13.
190. Zhou J, Chu H, Li C, Wong BH, Cheng ZS, Poon VK, Sun T, Lau CC, Wong KK, Chan JY, Chan JF, To KK, Chan KH, Zheng BJ, Yuen KY. 2014. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J Infect Dis 209: 1331-1342. http://dx.doi.org/10.1093/infdis/jit504.
191. Ziegler AF, Ladman BS, Dunn PA, Schneider A, Davison S, Miller PG, Lu H, Weinstock D, Salem M, Eckroade RJ, Gelb J, Jr. 2002. Nephropathogenic infectious bronchitis in Pennsylvania chickens 1997-2000. Avian Dis 46:847-858. http://dx.doi.org/10.1637/0005-2086(2002)0460847:NIBIPC2 .0.CO;2.
192. Chu H, Zhou J, Wong BH, Li C, Cheng ZS, Lin X, Poon VK, Sun T, Lau CC, Chan JF, To KK, Chan KH, Lu L, Zheng BJ, Yuen KY. 2014. Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response. Virology 454-455:197-205. http://dx.doi.org/10.1016/j.virol.2014.02.018.
193. Memish ZA, Al-Tawfiq JA, Makhdoom HQ, Assiri A, Alhakeem RF, Albarrak A, Alsubaie S, Al-Rabeeah AA, Hajomar WH, Hussain R, Kheyami AM, Almutairi A, Azhar EI, Drosten C, Watson SJ, Kellam P, Cotten M, Zumla A. 2014. Respiratory tract samples, viral load and genome fraction yield in patients with Middle East respiratory syndrome. J Infect Dis 210:1590-1594. http://dx.doi.org/10.1093/infdis/jiu292.
194. de Sousa R, Reusken C, Koopmans M. 2014. MERS coronavirus: data gaps for laboratory preparedness. J Clin Virol 59:4-11. http://dx.doi.org /10.1016/j.jcv.2013.10.030.
195. Cheng VC, Hung IF, Tang BS, Chu CM, Wong MM, Chan KH, Wu AK, Tse DM, Chan KS, Zheng BJ, Peiris JS, Sung JJ, Yuen KY. 2004. Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome. Clin Infect Dis 38:467-475. http://dx.doi.org/10.1086/382681.
196. Chan KH, Poon LL, Cheng VC, Guan Y, Hung IF, Kong J, Yam LY, Seto WH, Yuen KY, Peiris JS. 2004. Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis 10:294-299. http://dx .doi.org/10.3201/eid1002.030610.
197. Memish ZA, Assiri AM, Al-Tawfiq JA. 2014. Middle East respiratory syndrome coronavirus (MERS-CoV) viral shedding in the respiratory tract: an observational analysis with infection control implications. Int J Infect Dis 29:307-308. http://dx.doi.org/10.1016/j.ijid.2014.10.002.
198. Palm D, Pereyaslov D, Vaz J, Broberg E, Zeller H, Gross D, Brown CS, Struelens MJ. 2012. Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012. Euro Surveill 17(49):pii=20335. http://www.eurosurveillance .org/ViewArticle.aspx?ArticleId=20335.
199. Abd El Wahed A, Patel P, Heidenreich D, Hufert FT, Weidmann M. 2013. Reverse transcription recombinase polymerase amplification assay for the detection of middle East respiratory syndrome coronavirus. PLoS Curr 5:ecurrents.outbreaks.62df1c7c75ffc96cd59034531e2e8364. http://dx.doi .org/10.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364.
200. Shirato K, Yano T, Senba S, Akachi S, Kobayashi T, Nishinaka T, Notomi T, Matsuyama S. 2014. Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol J 11:139. http://dx.doi.org/10 .1186/1743-422X-11-139.
201. Agnihothram S, Gopal R, Yount BL, Jr, Donaldson EF, Menachery VD, Graham RL, Scobey TD, Gralinski LE, Denison MR, Zambon M, Baric RS. 2014. Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coro- naviruses to develop vaccine platforms for the rapid response to emerging coronaviruses. J Infect Dis 209:995-1006. http://dx.doi.org/10.1093 /infdis/jit609.
202. Chan KH, Chan JF, Tse H, Chen H, Lau CC, Cai JP, Tsang AK, Xiao X, To KK, Lau SK, Woo PC, Zheng BJ, Wang M, Yuen KY. 2013. Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests. J Infect 67:130-140. http://dx .doi.org/10.1016/j.jinf.2013.03.015.
203. Cheng VC, Tang BS, Wu AK, Chu CM, Yuen KY. 2004. Medical treatment of viral pneumonia including SARS in immunocompetent adult. J Infect 49:262-273. http://dx.doi.org/10.1016/j.jinf.2004.07.010.
204. Wong SS, Yuen KY. 2008. The management of coronavirus infections with particular reference to SARS. J Antimicrob Chemother 62:437-441. http://dx.doi.org/10.1093/jac/dkn243.
205. Ho PL, Sin WC, Chan JF, Cheng VC, Chan KH. 2014. Severe influenza A H7N9pneumonia with rapid virological response to intravenous zanamivir. Eur Respir J 44:535-537. http://dx.doi.org/10.1183/09031936.00006414.
206. Omrani AS, Saad MM, Baig K, Bahloul A, Abdul-Matin M, Alaidaroos AY, Almakhlafi GA, Albarrak MM, Memish ZA, Albarrak AM. 2014. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis 14:1090-1095. http://dx.doi.org/10.1016/S1473-3099(14)70920-X.
207. Frausto SD, Lee E, Tang H. 2013. Cyclophilins as modulators of viral replication. Viruses 5:1684-1701. http://dx.doi.org/10.3390/v5071684.
208. Falzarano D, de Wit E, Martellaro C, Callison J, Munster VJ, Feldmann H. 2013. Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin. Sci Rep 3:1686. http: //dx.doi.org/10.1038/srep01686.
209. Chan JF, Chan KH, Kao RY, To KK, Zheng BJ, Li CP, Li PT, Dai J, Mok FK, Chen H, Hayden FG, Yuen KY. 2013. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect 67:606-616. http://dx.doi.org/10.1016/j.jinf.2013.09.029.
210. Khalid M, Al Rabiah F, Khan B, Al Mobeireek A, Butt TS, Al Mutairy E. 15 May 2014. Ribavirin and interferon (IFN)-alpha-2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus (MERS-CoV): a preliminary report of two cases. Antivir Ther http://dx .doi.org/10.3851/IMP2792.
211. Dyall J, Coleman CM, Hart BJ, Venkataraman T, Holbrook MR, Kindrachuk J, Johnson RF, Olinger GG, Jr, Jahrling PB, Laidlaw M, Johansen LM, Lear-Rooney CM, Glass PJ, Hensley LE, Frieman MB. 2014. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother 58:4885-4893. http://dx.doi.org/10.1128/AAC.03036-14.
212. de Wilde AH, Jochmans D, Posthuma CC, Zevenhoven-Dobbe JC, van Nieuwkoop S, Bestebroer TM, van den Hoogen BG, Neyts J, Snijder EJ. 2014. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother 58:4875-4884. http://dx.doi.org/10.1128/AAC.03011-14.
213. Liu Q, Xia S, Sun Z, Wang Q, Du L, Lu L, Jiang S. 20 October 2014. Testing of MERS-CoV replication inhibitors for their ability to block viral entry. Antimicrob Agents Chemother http://dx.doi.org/10.1128 /AAC.03977-14.
214. Kindrachuk J, Ork B, Hart BJ, Mazur S, Holbrook MR, Frieman MB, Traynor D, Johnson RF, Dyall J, Kuhn JH, Olinger GG, Hensley LE, Jahrling PB. 8 December 2014. The antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for MERS-CoV infection as identified by temporal kinome analysis. Antimicrob Agents Chemother http://dx.doi.org/10.1128/AAC.03659-14.
215. Chu CM, Cheng VC, Hung IF, Wong MM, Chan KH, Chan KS, Kao RY, Poon LL, Wong CL, Guan Y, Peiris JS, Yuen KY. 2004. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 59:252-256. http://dx.doi.org/10.1136/thorax.2003 .012658.
216. Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, Seidah NG, Nichol ST. 2005. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2:69. http://dx.doi.org/10 .1186/1743-422X-2-69.
217. Barnard DL, Day CW, Bailey K, Heiner M, Montgomery R, Lauridsen L, Chan PK, Sidwell RW. 2006. Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice. Antivir Chem Chemother 17: 275-284.
218. Barnard DL, Kumaki Y. 2011. Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy. Future Virol 6:615-631. http://dx.doi.org/10.2217/fvl.11.33.
219. Kilianski A, Baker SC. 2014. Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitors. Antiviral Res 101:105-112. http://dx.doi.org/10.1016/j.antiviral.2013.11.004.
220. Yang ZY, Werner HC, Kong WP, Leung K, Traggiai E, Lanzavecchia A, Nabel GJ. 2005. Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. Proc Natl Acad Sci U S A 102:797-801. http://dx.doi.org/10.1073/pnas.0409065102.
221. Weingartl H, Czub M, Czub S, Neufeld J, Marszal P, Gren J, Smith G, Jones S, Proulx R, Deschambault Y, Grudeski E, Andonov A, He R, Li Y, Copps J, Grolla A, Dick D, Berry J, Ganske S, Manning L, Cao J. 2004. Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J Virol 78:12672-12676. http://dx.doi .org/10.1128/JVI.78.22.12672-12676.2004.
222. Ren Z, Yan L, Zhang N, Guo Y, Yang C, Lou Z, Rao Z. 2013. The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease. Protein Cell 4:248-250. http://dx.doi.org/10.1007/s13238-013-2841-3.
223. Kilianski A, Mielech AM, Deng X, Baker SC. 2013. Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papainlike and 3C-like proteases using luciferase-based biosensors. J Virol 87: 11955-11962. http://dx.doi.org/10.1128/JVI.02105-13.
224. Agnihothram S, Yount BL, Jr, Donaldson EF, Huynh J, Menachery VD, Gralinski LE, Graham RL, Becker MM, Tomar S, Scobey TD, Osswald HL, Whitmore A, Gopal R, Ghosh AK, Mesecar A, Zambon M, Heise M, Denison MR, Baric RS. 2014. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant. mBio 5(2):e00047- 00014. http://dx.doi.org/10.1128/mBio.00047-14.
225. Adedeji AO, Singh K, Kassim A, Coleman CM, Elliott R, Weiss SR, Frieman MB, Sarafianos SG. 2014. Evaluation of SSYA10-001 as a replication inhibitor of SARS,MHVand MERS coronaviruses. Antimicrob Agents Chemother 58:4894-4898. http://dx.doi.org/10.1128/AAC.02994-14.
226. Bosch BJ, Smits SL, Haagmans BL. 2014. Membrane ectopeptidases targeted by human coronaviruses. Curr Opin Virol 6:55-60. http://dx .doi.org/10.1016/j.coviro.2014.03.011.
227. Reinhold D, Bank U, Tager M, Ansorge S, Wrenger S, Thielitz A, Lendeckel U, Faust J, Neubert K, Brocke S. 2008. DP IV/CD26, APN/ CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis. Front Biosci 13:2356-2363. http://dx.doi.org/10.2741/2849.
228. Reinhold D, Brocke S. 2014. DPP4-directed therapeutic strategies for MERS-CoV. Lancet Infect Dis 14:100-101. http://dx.doi.org/10.1016 /S1473-3099(13)70696-0.
229. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. 2005. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643-1645. http://dx.doi.org/10.1126/science .1110656.
230. Marzi A, Reinheckel T, Feldmann H. 2012. Cathepsin B & L are not required for ebola virus replication. PLoS Negl Trop Dis 6:e1923. http: //dx.doi.org/10.1371/journal.pntd.0001923.
231. Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, Yao H, Wo J, Fang Q, Cui D, Li Y, Yao X, Zhang Y, Wu H, Zheng S, Diao H, Xia S, Chan KH, Tsoi HW, Teng JL, Song W, Wang P, Lau SY, Zheng M, Chan JF, To KK, Chen H, Li L, Yuen KY. 2013. Human infections with the emerging avian influenzaAH7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381:1916-1925. http://dx.doi.org/10.1016/S0140-6736(13)60903-4.
232. To KK, Tsang AK, Chan JF, Cheng VC, Chen H, Yuen KY. 2014. Emergence in China of human disease due to avian influenza A(H10N8)-cause for concern? J Infect 68:205-215. http://dx.doi.org /10.1016/j.jinf.2013.12.014.
233. Cheng VC, Chan JF, To KK, Yuen KY. 2013. Clinical management and infection control of SARS: lessons learned. Antiviral Res 100:407-419. http://dx.doi.org/10.1016/j.antiviral.2013.08.016.
234. Memish ZA, Al-Tawfiq JA, Assiri A. 2013. Hospital-associated Middle East respiratory syndrome coronavirus infections. N Engl J Med 369: 1761-1762. http://dx.doi.org/10.1056/NEJMc1311004.
235. Coburn BJ, Blower S. 2014. Predicting the potential for within-flight transmission and global dissemination of MERS. Lancet Infect Dis 14:99. http://dx.doi.org/10.1016/S1473-3099(13)70358-X.
236. Thomas HL, Zhao H, Green HK, Boddington NL, Carvalho CF, Osman HK, Sadler C, Zambon M, Bermingham A, Pebody RG. 2014. Enhanced MERS coronavirus surveillance of travelers from the Middle East to England. Emerg Infect Dis 20:1562-1564. http://dx.doi.org/10 .3201/eid2009.140817.
237. Leclercq I, Batejat C, Burguiere AM, Manuguerra JC. 2014. Heat inactivation of the Middle East respiratory syndrome coronavirus. Influenza Other Respir Viruses 8:585-586. http://dx.doi.org/10.1111/irv.12261.
238. Gautret P, Charrel R, Belhouchat K, Drali T, Benkouiten S, Nougairede A, Zandotti C, Memish ZA, al Masri M, Gaillard C, Brouqui P, Parola P. 2013. Lack of nasal carriage of novel corona virus (HCoVEMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms. Clin Microbiol Infect 19:E315-E317. http://dx.doi.org/10.1111/1469-0691.12174.
239. Gautret P, Charrel R, Benkouiten S, Belhouchat K, Nougairede A, Drali T, Salez N, Memish ZA, Al Masri M, Lagier JC, Million M, Raoult D, Brouqui P, Parola P. 2014. Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis 20:728-730. http://dx.doi.org/10.3201/eid2004.131708.
240. Memish ZA, Almasri M, Turkestani A, Al-Shangiti AM, Yezli S. 2014. Etiology of severe community-acquired pneumonia during the 2013 Hajj-part of the MERS-CoV surveillance program. Int J Infect Dis 25: 186-190. http://dx.doi.org/10.1016/j.ijid.2014.06.003.
241. Memish ZA, Al-Rabeeah AA. 2013. Health conditions of travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj and Umra) for 1434 (2013). J Epidemiol Glob Health 3:59-61. http://dx.doi.org/10.1016/j .jegh.2013.03.001.
242. Al-Tawfiq JA, Memish ZA. 2014. Mass gathering medicine: 2014 Hajj and Umra preparation as a leading example. Int J Infect Dis 27:26-31. http://dx.doi.org/10.1016/j.ijid.2014.07.001.
243. Chung SJ, Ling ML, Seto WH, Ang BS, Tambyah PA. 2014. Debate on MERS-CoV respiratory precautions: surgical mask or N95 respirators? Singapore Med J 55:294-297. http://dx.doi.org/10.11622/smedj.2014076.
244. Cheng VC, Tai JW, Wong LM, Chan JF, Li IW, To KK, Hung IF, Chan KH, Ho PL, Yuen KY. 2010. Prevention of nosocomial transmission of swine-origin pandemic influenza virus A/H1N1 by infection control bundle. J Hosp Infect 74:271-277. http://dx.doi.org/10.1016/j.jhin.2009 .09.009.
245. Al-Gethamy M, Corman VM, Hussain R, Al-Tawfiq JA, Drosten C, Memish ZA. 16 December 2014. A case of long-term excretion and subclinical infection with MERS-Coronavirus in a health care worker. Clin Infect Dis http://dx.doi.org/10.1093/cid/ciu1135.
246. Madani TA. 2014. Case definition and management of patients with MERS coronavirus in Saudi Arabia. Lancet Infect Dis 14:911-913. http: //dx.doi.org/10.1016/S1473-3099(14)70918-1.
247. Song F, Fux R, Provacia LB, Volz A, Eickmann M, Becker S, Osterhaus AD, Haagmans BL, Sutter G. 2013. Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies. J Virol 87:11950 - 11954. http://dx.doi.org/10.1128/JVI.01672-13.
248. Coleman CM, Liu YV, Mu H, Taylor JK, Massare M, Flyer DC, Glenn GM, Smith GE, Frieman MB. 2014. Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine 32:3169-3174. http://dx.doi.org/10.1016/j.vaccine.2014.04.016.
249. He Y, Zhou Y, Wu H, Luo B, Chen J, Li W, Jiang S. 2004. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines. J Immunol 173:4050-4057. http://dx.doi.org /10.4049/jimmunol.173.6.4050.
250. Lan J, Deng Y, Chen H, Lu G, Wang W, Guo X, Lu Z, Gao GF, Tan W. 2014. Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen. PLoS One 9:e112602. http://dx.doi.org/10.1371/journal.pone.0112602.
251. Zhang N, Jiang S, Du L. 2014. Current advancements and potential strategies in the development of MERS-CoV vaccines. Expert Rev Vaccines 13:761-774. http://dx.doi.org/10.1586/14760584.2014.912134.
252. Cheng Y, Wong R, Soo YO, Wong WS, Lee CK, Ng MH, Chan P, Wong KC, Leung CB, Cheng G. 2005. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis 24:44-46. http://dx.doi.org/10.1007/s10096-004-1271-9.
253. Yeh KM, Chiueh TS, Siu LK, Lin JC, Chan PK, Peng MY, Wan HL, Chen JH, Hu BS, Perng CL, Lu JJ, Chang FY. 2005. Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital. J Antimicrob Chemother 56: 919-922. http://dx.doi.org/10.1093/jac/dki346.
254. Hung IF, To KK, Lee CK, Lee KL, Yan WW, Chan K, Chan WM, Ngai CW, Law KI, Chow FL, Liu R, Lai KY, Lau CC, Liu SH, Chan KH, Lin CK, Yuen KY. 2013. Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection. Chest 144:464-473. http://dx .doi.org/10.1378/chest.12-2907.
255. Hung IF, To KK, Lee CK, Lee KL, Chan K, Yan WW, Liu R, Watt CL, Chan WM, Lai KY, Koo CK, Buckley T, Chow FL, Wong KK, Chan HS, Ching CK, Tang BS, Lau CC, Li IW, Liu SH, Chan KH, Lin CK, Yuen KY. 2011. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis 52:447-456. http://dx.doi.org/10.1093/cid/ciq106.
256. van Doremalen N, de Wit E, Falzarano D, Scott DP, Schountz T, Bowen D, McLellan JS, Zhu J, Munster VJ. 2014. Modeling the host ecology of Middle East respiratory syndrome coronavirus (MERS-CoV): from host reservoir to disease. Final Progr 33rd Annu MeetAmSoc Virol, Fort Collins, CO.
257. Adney DR, Brown VR, Dominguez SR, Bielefeldt-Ohmann H, Bowen RA. 2014. Experimental infectioin of goats and insectivorous bats with MERS-CoV. Final Progr 33rd Annu Meet Am Soc Virol, Fort Collins, CO.
258. Adney DR, van Doremalen N, Brown VR, Bushmaker T, Scott D, de Wit E, Bowen RA, Munster VJ. 2014. Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels. Emerg Infect Dis 20:1999-2005. http://dx.doi.org/10.3201/eid2012.141280.
259. Poon LL, Chu DK, Chan KH, Wong OK, Ellis TM, Leung YH, Lau SK, Woo PC, Suen KY, Yuen KY, Guan Y, Peiris JS. 2005. Identification of a novel coronavirus in bats. J Virol 79:2001-2009. http://dx.doi.org/10 .1128/JVI.79.4.2001-2009.2005.
260. Woo PC, Lau SK, Huang Y, Tsoi HW, Chan KH, Yuen KY. 2005. Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirus from patients with pneumonia. Arch Virol 150:2299-2311. http://dx.doi.org/10.1007/s00705-005-0573-2.
261. Woo PC, Huang Y, Lau SK, Tsoi HW, Yuen KY. 2005. In silico analysis of ORF1ab in coronavirus HKU1 genome reveals a unique putative cleavage site of coronavirus HKU1 3C-like protease. Microbiol Immunol 49:899-908. http://dx.doi.org/10.1111/j.1348-0421.2005.tb03681.x.
262. Woo PC, Lau SK, Yip CC, Huang Y, Tsoi HW, Chan KH, Yuen KY. 2006. Comparative analysis of 22 coronavirus HKU1 genomes reveals a novel genotype and evidence of natural recombination in coronavirus HKU1. J Virol 80:7136-7145. http://dx.doi.org/10.1128/JVI.00509-06.
263. Huang Y, Lau SK, Woo PC, Yuen KY. 2008. CoVDB: a comprehensive database for comparative analysis of coronavirus genes and genomes. Nucleic Acids Res 36:D504-D511. http://dx.doi.org/10.1093/nar/gkm754.
264. Woo PC, Lau SK, Lam CS, Lai KK, Huang Y, Lee P, Luk GS, Dyrting KC, Chan KH, Yuen KY. 2009. Comparative analysis of complete genome sequences of three avian coronaviruses reveals a novel group 3c coronavirus. J Virol 83:908-917. http://dx.doi.org/10.1128/JVI.01977-08.
265. Woo PC, Lau SK, Yip CC, Huang Y, Yuen KY. 2009. More and more coronaviruses: human coronavirus HKU1. Viruses 1:57-71. http://dx .doi.org/10.3390/v1010057.
266. Woo PC, Huang Y, Lau SK, Yuen KY. 2010. Coronavirus genomics and bioinformatics analysis. Viruses 2:1804-1820. http://dx.doi.org/10.3390 /v2081803.
267. Lau SK, Lee P, Tsang AK, Yip CC, Tse H, Lee RA, So LY, Lau YL, Chan KH, Woo PC, Yuen KY. 2011. Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination. J Virol 85:11325-11337. http://dx.doi.org/10.1128/JVI.05512-11.
268. Lau SK, Woo PC, Yip CC, Fan RY, Huang Y, Wang M, Guo R, Lam CS, Tsang AK, Lai KK, Chan KH, Che XY, Zheng BJ, Yuen KY. 2012. Isolation and characterization of a novel Betacoronavirus subgroup A coronavirus, rabbit coronavirus HKU14, from domestic rabbits. J Virol 86:5481-5496. http://dx.doi.org/10.1128/JVI.06927-11.
269. Woo PC, Lau SK, Lam CS, Tsang AK, Hui SW, Fan RY, Martelli P, Yuen KY. 2014. Discovery of a novel bottlenose dolphin coronavirus reveals a distinct species of marine mammal coronavirus in Gammacoronavirus. J Virol 88:1318-1331. http://dx.doi.org/10.1128/JVI.02351-13.
270. Pereyaslov D, Rosin P, Palm D, Zeller H, Gross D, Brown C, Struelens M. 2014. Laboratory capability and surveillance testing for Middle East respiratory syndrome coronavirus infection in the WHO European Region, June 2013. Euro Surveill 19(40):pii=20923. http://www.eurosurveillance.org /ViewArticle.aspx?ArticleId=20923.
271. Woo PC, Lau SK, Teng JL, Tsang AK, Joseph M, Wong EY, Tang Y, Sivakumar S, Xie J, Bai R, Wernery R, Wernery U, Yuen KY. 2014. New hepatitis E virus genotype in camels, the Middle East. Emerg Infect Dis 20:1044-1048. http://dx.doi.org/10.3201/eid2006.140140.
272. Woo PC, Lau SK, Teng JL, Tsang AK, Joseph M, Wong EY, Tang Y, Sivakumar S, Bai R, Wernery R, Wernery U, Yuen KY. 2014. Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses. Virology 471-473C:117-125. http://dx.doi.org/10.1016/j.virol.2014.09.020.
273. Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, Wang H, Crameri G, Hu Z, Zhang H, Zhang J, McEachern J, Field H, Daszak P, Eaton BT, Zhang S, Wang LF. 2005. Bats are natural reservoirs of SARS-like coronaviruses. Science 310:676-679. http://dx.doi.org/10.1126/science.1118391.
274. Ge XY, Li JL, Yang XL, Chmura AA, Zhu G, Epstein JH, Mazet JK, Hu B, Zhang W, Peng C, Zhang YJ, Luo CM, Tan B, Wang N, Zhu Y, Crameri G, Zhang SY, Wang LF, Daszak P, Shi ZL. 2013. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 503:535-538. http://dx.doi.org/10.1038/nature12711.
275. Chu CM, Cheng VC, Hung IF, Chan KS, Tang BS, Tsang TH, Chan KH, Yuen KY. 2005. Viral load distribution in SARS outbreak. Emerg Infect Dis 11:1882-1886. http://dx.doi.org/10.3201/eid1112.040949.
276. Lim PL, Kurup A, Gopalakrishna G, Chan KP, Wong CW, Ng LC, Se-Thoe SY, Oon L, Bai X, Stanton LW, Ruan Y, Miller LD, Vega VB, James L, Ooi PL, Kai CS, Olsen SJ, Ang B, Leo YS. 2004. Laboratoryacquired severe acute respiratory syndrome. N Engl J Med 350:1740-1745. http://dx.doi.org/10.1056/NEJMoa032565.
277. Olsen SJ, Chang HL, Cheung TY, Tang AF, Fisk TL, Ooi SP, Kuo HW, Jiang DD, Chen KT, Lando J, Hsu KH, Chen TJ, Dowell SF. 2003. Transmission of the severe acute respiratory syndrome on aircraft. N Engl J Med 349:2416-2422. http://dx.doi.org/10.1056/NEJMoa031349.
278. Anderson RM, Fraser C, Ghani AC, Donnelly CA, Riley S, Ferguson NM, Leung GM, Lam TH, Hedley AJ. 2004. Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci 359:1091-1105. http://dx.doi.org/10.1098 /rstb.2004.1490.
279. Wallinga J, Teunis P. 2004. Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. Am J Epidemiol 160:509-516. http://dx.doi.org/10.1093/aje/kwh255.
280. Nishiura H, Kuratsuji T, Quy T, Phi NC, Van Ban V, Ha LE, Long HT, Yanai H, Keicho N, Kirikae T, Sasazuki T, Anderson RM. 2005. Rapid awareness and transmission of severe acute respiratory syndrome in Hanoi French Hospital, Vietnam. Am J Trop Med Hyg 73:17-25.
281. Fouchier RA, Kuiken T, Schutten M, van Amerongen G, van Doornum GJ, van den Hoogen BG, Peiris M, Lim W, Stohr K, Osterhaus AD. 2003. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423:240. http://dx.doi.org/10.1038/423240a.
282. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450-454. http://dx.doi.org/10 .1038/nature02145.
283. Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, Bates P. 2005. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A 102:11876- 11881. http://dx.doi.org/10.1073/pnas.0505577102.
284. Glowacka I, Bertram S, Muller MA, Allen P, Soilleux E, Pfefferle S, Steffen I, Tsegaye TS, He Y, Gnirss K, Niemeyer D, Schneider H, Drosten C, Pohlmann S. 2011. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol 85:4122-4134. http://dx.doi.org/10.1128/JVI.02232-10.
285. Matsuyama S, Nagata N, Shirato K, Kawase M, Takeda M, Taguchi F. 2010. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol 84:12658-12664. http://dx.doi.org/10.1128/JVI.01542-10.
286. Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pohlmann S. 2014. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol 88:1293-1307. http://dx.doi.org/10.1128/JVI.02202-13.
287. Huang IC, Bosch BJ, Li F, Li W, Lee KH, Ghiran S, Vasilieva N, Dermody TS, Harrison SC, Dormitzer PR, Farzan M, Rottier PJ, Choe H. 2006. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J Biol Chem 281:3198-3203. http://dx.doi.org/10.1074/jbc.M508381200.
288. Siu KL, Kok KH, Ng MH, Poon VK, Yuen KY, Zheng BJ, Jin DY. 2009. Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex. J Biol Chem 284:16202- 16209. http://dx.doi.org/10.1074/jbc.M109.008227.
289. Kopecky-Bromberg SA, Martinez-Sobrido L, Frieman M, Baric RA, Palese P. 2007. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol 81:548-557. http://dx.doi.org/10.1128 /JVI.01782-06.
290. Narayanan K, Huang C, Lokugamage K, Kamitani W, Ikegami T, Tseng CT, Makino S. 2008. Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J Virol 82:4471-4479. http://dx.doi.org/10 .1128/JVI.02472-07.
291. Devaraj SG, Wang N, Chen Z, Tseng M, Barretto N, Lin R, Peters CJ, Tseng CT, Baker SC, Li K. 2007. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J Biol Chem 282:32208-32221. http://dx .doi.org/10.1074/jbc.M704870200.
292. Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, Poon LL, Guan Y, Rozanov M, Spaan WJ, Gorbalenya AE. 2003. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 331:991-1004. http://dx.doi.org/10.1016/S0022-2836(03)00865-9.
293. Woo PC, Lau SK, Tsoi HW, Chan KH, Wong BH, Che XY, Tam VK, Tam SC, Cheng VC, Hung IF, Wong SS, Zheng BJ, Guan Y, Yuen KY. 2004. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet 363:841-845. http://dx.doi.org /10.1016/S0140-6736(04)15729-2.
294. Nie Y, Wang G, Shi X, Zhang H, Qiu Y, He Z, Wang W, Lian G, Yin X, Du L, Ren L, Wang J, He X, Li T, Deng H, Ding M. 2004. Neutralizing antibodies in patients with severe acute respiratory syndrome- associated coronavirus infection. J Infect Dis 190:1119-1126. http://dx.doi.org/10.1086/423286.
295. Graham RL, Donaldson EF, Baric RS. 2013. A decade after SARS: strategies for controlling emerging coronaviruses. Nat Rev Microbiol 11:836-848. http://dx.doi.org/10.1038/nrmicro3143.
296. Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR. 2015. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 211:80-90. http://dx.doi.org/10.1093/infdis/jiu396.
297. Pfefferle S, Schopf J, Kogl M, Friedel CC, Muller MA, Carbajo-Lozoya J, Stellberger T, von Dall'Armi E, Herzog P, Kallies S, Niemeyer D, Ditt V, Kuri T, Zust R, Pumpor K, Hilgenfeld R, Schwarz F, Zimmer R, Steffen I, Weber F, Thiel V, Herrler G, Thiel HJ, Schwegmann- Wessels C, Pohlmann S, Haas J, Drosten C, von Brunn A. 2011. The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog 7:e1002331. http://dx .doi.org/10.1371/journal.ppat.1002331.
298. Huang C, Lokugamage KG, Rozovics JM, Narayanan K, Semler BL, Makino S. 2011. SARS coronavirus nsp1 protein induces templatedependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage. PLoS Pathog 7:e1002433. http://dx .doi.org/10.1371/journal.ppat.1002433.
299. Cornillez-Ty CT, Liao L, Yates JR 3rd, Kuhn P, Buchmeier MJ. 2009. Severe acute respiratory syndrome coronavirus nonstructural protein 2 interacts with a host protein complex involved in mitochondrial biogenesis and intracellular signaling. J Virol 83:10314-10318. http://dx.doi .org/10.1128/JVI.00842-09.
300. Lin MH, Chuang SJ, Chen CC, Cheng SC, Cheng KW, Lin CH, Sun CY, Chou CY. 2014. Structural and functional characterization of MERS coronavirus papain-like protease. J Biomed Sci 21:54. http://dx.doi.org /10.1186/1423-0127-21-54.
301. Baez-Santos YM, Mielech AM, Deng X, Baker S, Mesecar AD. 2014. Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus. J Virol 88:12511-12527. http://dx.doi.org/10.1128/JVI.01294-14.
302. Lei J, Mesters JR, Drosten C, Anemuller S, Ma Q, Hilgenfeld R. 2014. Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features. Antiviral Res 109:72-82. http://dx.doi.org/10.1016/j.antiviral.2014.06.011.
303. Bailey-Elkin BA, Knaap RC, Johnson GG, Dalebout TJ, Ninaber DK, van Kasteren PB, Bredenbeek PJ, Snijder EJ, Kikkert M, Mark BL. 15 October 2014. Crystal structure of the MERS coronavirus papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression. J Biol Chem http://dx.doi.org/10.1074/jbc.M114.609644.
304. Lundin A, Dijkman R, Bergstrom T, Kann N, Adamiak B, Hannoun C, Kindler E, Jonsdottir HR, Muth D, Kint J, Forlenza M, Muller MA, Drosten C, Thiel V, Trybala E. 2014. Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus. PLoS Pathog 10: e1004166. http://dx.doi.org/10.1371/journal.ppat.1004166.
305. te Velthuis AJ, van den Worm SH, Snijder EJ. 2012. The SARScoronavirus nsp7_nsp8 complex is a unique multimeric RNA polymerase capable of both de novo initiation and primer extension. Nucleic Acids Res 40:1737-1747. http://dx.doi.org/10.1093/nar/gkr893.
306. Miknis ZJ, Donaldson EF, Umland TC, Rimmer RA, Baric RS, Schultz LW. 2009. Severe acute respiratory syndrome coronavirus nsp9 dimerization is essential for efficient viral growth. J Virol 83:3007-3018. http://dx.doi.org/10.1128/JVI.01505-08.
307. Chen Y, Su C, Ke M, Jin X, Xu L, Zhang Z, Wu A, Sun Y, Yang Z, Tien P, Ahola T, Liang Y, Liu X, Guo D. 2011. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2=-Omethylation by nsp16/nsp10 protein complex. PLoS Pathog 7:e1002294. http://dx.doi.org/10.1371/journal.ppat.1002294.
308. Menachery VD, Debbink K, Baric RS. 2014. Coronavirus nonstructural protein 16: evasion, attenuation, and possible treatments. Virus Res 194C:191-199. http://dx.doi.org/10.1016/j.virusres.2014.09.009.
309. Almazan F, DeDiego ML, Sola I, Zuniga S, Nieto-Torres JL, Marquez- Jurado S, Andres G, Enjuanes L. 2013. Engineering a replicationcompetent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. mBio 4(5):e00650-00613. http://dx .doi.org/10.1128/mBio.00650-13.
310. Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, van Boheemen S, Gopal R, Ballhause M, Bestebroer TM, Muth D, Muller MA, Drexler JF, Zambon M, Osterhaus AD, Fouchier RM, Drosten C. 2012. Detection of a novel human coronavirus by real-time reversetranscription polymerase chain reaction. Euro Surveill 17(39):pii=20285. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20285.
311. Saad M, Omrani AS, Baig K, Bahloul A, Elzein F, Matin MA, Selim MA, Mutairi MA, Nakhli DA, Aidaroos AY, Sherbeeni NA, Al- Khashan HI, Memish ZA, Albarrak AM. 7 October 2014. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis http://dx.doi.org/10.1016/j.ijid.2014.09.003.
312. Yang L, Wu Z, Ren X, Yang F, Zhang J, He G, Dong J, Sun L, Zhu Y, Zhang S, Jin Q. 2014. MERS-related betacoronavirus in Vespertilio superans bats, China. Emerg Infect Dis 20:1260-1262. http://dx.doi.org /10.3201/eid2007.140318.
313. Annan A, Baldwin HJ, Corman VM, Klose SM, Owusu M, Nkrumah EE, Badu EK, Anti P, Agbenyega O, Meyer B, Oppong S, Sarkodie YA, Kalko EK, Lina PH, Godlevska EV, Reusken C, Seebens A, Gloza-Rausch F, Vallo P, Tschapka M, Drosten C, Drexler JF. 2013. Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg Infect Dis 19:456-459. http://dx.doi.org/10.3201/eid1903.121503.
314. Lelli D, Papetti A, Sabelli C, Rosti E, Moreno A, Boniotti MB. 2013. Detection of coronaviruses in bats of various species in Italy. Viruses 5:2679-2689. http://dx.doi.org/10.3390/v5112679.
315. Anthony SJ, Ojeda-Flores R, Rico-Chavez O, Navarrete-Macias I, Zambrana-Torrelio CM, Rostal MK, Epstein JH, Tipps T, Liang E, Sanchez-Leon M, Sotomayor-Bonilla J, Aguirre AA, Avila-Flores R, Medellin RA, Goldstein T, Suzan G, Daszak P, Lipkin WI. 2013. Coronaviruses in bats from Mexico. J Gen Virol 94:1028-1038. http://dx .doi.org/10.1099/vir.0.049759-0.
316. Goes LG, Ruvalcaba SG, Campos AA, Queiroz LH, de Carvalho C, Jerez JA, Durigon EL, Davalos LI, Dominguez SR. 2013. Novel bat coronaviruses, Brazil and Mexico. Emerg Infect Dis 19:1711-1713. http: //dx.doi.org/10.3201/eid1910.130525.
317. Nowotny N, Kolodziejek J. 2014. Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013. Euro Surveill 19(16):pii=20781. http://www.eurosurveillance.org/View Article.aspx?ArticleId=20781.
318. Reusken CB, Messadi L, Feyisa A, Ularamu H, Godeke GJ, Danmarwa A, Dawo F, Jemli M, Melaku S, Shamaki D, Woma Y, Wungak Y, Gebremedhin EZ, Zutt I, Bosch BJ, Haagmans BL, Koopmans MP. 2014. Geographic distribution of MERS coronavirus among dromedary camels, Africa. Emerg Infect Dis 20:1370-1374. http://dx.doi.org/10 .3201/eid2008.140590.
319. Cai Y, Yú SQ Postnikova EN, Mazur S, Bernbaum JG, Burk R, Zha_ng T, Radoshitzky SR, Müller MA, Jordan I, Bollinger L, Hensley LE, Jahrling PB, Kuhn JH. 2014. CD26/DPP4 cell-surface expression in bat cells correlates with bat cell susceptibility to Middle East respiratory syndrome coronavirus (MERS-CoV) infection and evolution of persistent infection. PLoS One 9:e112060. http://dx.doi.org/10.1371/journal.pone .0112060.
320. Payne DC, Iblan I, Alqasrawi S, Al Nsour M, Rha B, Tohme RA, Abedi GR, Farag NH, Haddadin A, Al Sanhouri T, Jarour N, Swerdlow DL, Jamieson DJ, Pallansch MA, Haynes LM, Gerber SI, Al Abdallat MM. 2014. Stillbirth during infection with Middle East respiratory syndrome coronavirus. J Infect Dis 209:1870-1872. http://dx.doi.org/10.1093/infdis /jiu068.
321. Corman VM, Olschlager S, Wendtner CM, Drexler JF, Hess M, Drosten C. 2014. Performance and clinical validation of the RealStar MERS-CoV kit for detection of Middle East respiratory syndrome coronavirus RNA. J Clin Virol 60:168-171. http://dx.doi.org/10.1016/j.jcv.2014.03.012.
322. Lu X, Whitaker B, Sakthivel SK, Kamili S, Rose LE, Lowe L, Mohareb E, Elassal EM, Al-sanouri, Haddadin TA, Erdman DD. 2014. Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus. J Clin Microbiol 52:67-75. http://dx.doi.org/10.1128/JCM .02533-13.
323. Reusken C, Mou H, Godeke GJ, van der Hoek L, Meyer B, Muller MA, Haagmans B, de Sousa R, Schuurman N, Dittmer U, Rottier P, Osterhaus A, Drosten C, Bosch BJ, Koopmans M. 2013. Specific serology for emerging human coronaviruses by protein microarray. Euro Surveill 18(14):pii=20441. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20441.
324. Hart BJ, Dyall J, Postnikova E, Zhou H, Kindrachuk J, Johnson RF, Olinger GG, Jr, Frieman MB, Holbrook MR, Jahrling PB, Hensley L. 2014. Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. J Gen Virol 95:571-577. http://dx.doi.org/10.1099/vir.0.061911-0.
325. Tao X, Mei F, Agrawal A, Peters CJ, Ksiazek TG, Cheng X, Tseng CT. 2014. Blocking of exchange proteins directly activated by cAMP leads to reduced replication of Middle East respiratory syndrome coronavirus. J Virol 88:3902-3910. http://dx.doi.org/10.1128/JVI.03001-13.
326. Al-Tawfiq JA, Momattin H, Dib J, Memish ZA. 2014. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis 20:42-46. http://dx.doi.org/10.1016/j.ijid.2013.12.003.
327. de Wit E, Prescott J, Baseler L, Bushmaker T, Thomas T, Lackemeyer MG, Martellaro C, Milne-Price S, Haddock E, Haagmans BL, Feldmann H, Munster VJ. 2013. The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters. PLoS One 8:e69127. http://dx.doi.org/10.1371/journal.pone.0069127.
328. Coleman CM, Matthews KL, Goicochea L, Frieman MB. 2014. Wildtype and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus. J Gen Virol 95:408-412. http: //dx.doi.org/10.1099/vir.0.060640-0.
329. Chan JF, To KK, Chen H, Yuen KY. 2015. Cross-species transmission and emergence of novel viruses from birds. Curr Opin Virol 10C:63-69. http://dx.doi.org/10.1016/j.coviro.2015.01.006.
330. Loon SC, Teoh SC, Oon LL, Se-Thoe SY, Ling AE, Leo YS, Leong HN. 2004. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol 88:861-863.
331. Wang WK, Chen SY, Liu IJ, Chen YC, Chen HL, Yang CF, Chen PJ, Yeh SH, Kao CL, Huang LM, Hsueh PR, Wang JT, Sheng WH, Fang CT, Hung CC, Hsieh SM, Su CP, Chiang WC, Yang JY, Lin JH, Hsieh SC, Hu HP, Chiang YP, Wang JT, Yang PC, Chang SC; SARS Research Group of the National Taiwan University/National Taiwan University Hospital. 2004. Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg Infect Dis 10:1213-1219.
332. Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, Wang H, Shen H, Qiu L, Li Z, Geng J, Cai J, Han H, Li X, Kang W, Weng D, Liang P, Jiang S. 2004. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 203:622-630.
333. Agrawal AS, Garron T, Tao X, Peng BH, Wakamiya M, Chan TS, Couch RB, Tseng CT. 14 January 2015. Generation of transgenic mouse model of Middle East respiratory syndrome-coronavirus infection and disease. J Virol http://dx.doi.org/10.1128/JVI.03427-14.
334. Shalhoub S, AlZahrani A, Simhairi R, Mushtaq A. 2015. Successful recovery of MERS CoV pneumonia in a patient with acquired immunodeficiency syndrome: a case report. J Clin Virol 62:69-71. http://dx.doi .org/10.1016/j.jcv.2014.11.030.
335. AlGhamdi M, Mushtaq F, Awn N, Shalhoub S. 25 February 2015. MERS CoV infection in two renal transplant recipients: case report. Am J Transplant http://dx.doi.org/10.1111/ajt.13085.
336. Meyer B, García-Bocanegra I, Wernery U, Wernery R, Sieberg A, Müller MA, Drexler JF, Drosten C, Eckerle I 2015. Serologic assessment of possibility for MERS-CoV infection in equids. Emerg Infect Dis 21: 181-182. http://dx.doi.org/10.3201/eid2101.141342.
337. Gossner C, Danielson N, Gervelmeyer A, Berthe F, Faye B, Kaasik Aaslav K, Adlhoch C, Zeller H, Penttinen P, Coulombier D. 27 December 2014. Human-dromedary camel interactions and the risk of acquiring zoonotic Middle East respiratory syndrome coronavirus infection. Zoonoses Public Health http://dx.doi.org/10.1111/zph.12171.
338. Chan RW, Hemida MG, Kayali G, Chu DK, Poon LL, Alnaeem A, Ali MA, Tao KP, Ng HY, Chan MC, Guan Y, Nicholls JM, Peiris JS 2014. Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study. Lancet Respir Med 2:813-822. http://dx.doi.org/10 .1016/S2213-2600(14)70158-4.
339. Majumder MS, Rivers C, Lofgren E, Fisman D. 18 December 2014. Estimation of MERS-coronavirus reproductive number and case fatality rate for the spring 2014 Saudi Arabia outbreak: insights from publicly available data. PLoS Curr 6. http://dx.doi.org/10.1371/currents .outbreaks.98d2f8f3382d84f390736cd5f5fe133c.
340. Song D, Ha G, Serhan W, Eltahir Y, Yusof M, Hashem F, Elsayed E, Marzoug B, Abdelazim A, Al Muhairi S. 2015. Development and validation of a rapid immunochromatographic assay for the detection of Middle East respiratory syndrome coronavirus antigen in dromedary camels. J Clin Microbiol 53:1178-1182. http://dx.doi.org/10.1128/JCM .03096-14.
341. Cheng KW, Cheng SC, Chen WY, Lin MH, Chuang SJ, Cheng IH, Sun CY, Chou CY. 2015. Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus. Antiviral Res 115:9-16. http://dx.doi.org/10.1016/j .antiviral.2014.12.011.
342. Maltezou HC, Tsiodras S. 2014. Middle East respiratory syndrome coronavirus: implications for health care facilities. Am J Infect Control 42:1261-1265. http://dx.doi.org/10.1016/j.ajic.2014.06.019.
343. Cheng VC, Tai JW, Lee WM, Chan WM, Wong SC, Chen JH, Poon RW, To KK, Chan JF, Ho PL, Chan KH, Yuen KY. 2015. Infection control preparedness for human infection with influenza A H7N9 in Hong Kong. Infect Control Hosp Epidemiol 36:87-92. http://dx.doi.org /10.1017/ice.2014.2.
344. Zhang N, Channappanavar R, Ma C, Wang L, Tang J, Garron T, Tao X, Tasneem S, Lu L, Tseng CT, Zhou Y, Perlman S, Jiang S, Du L. 2 February 2015. Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus. Cell Mol Immunol http://dx.doi.org/10.1038/cmi .2015.03.
345. Yavarian J, Rezaei F, Shadab A, Soroush M, Gooya MM, Azad TM. 2015. Cluster of Middle East respiratory syndrome coronavirus infections in Iran, 2014. Emerg Infect Dis 21:362-364. http://dx.doi.org/10 .3201/eid2102.141405.